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ABSTRACT 
 
Will Stanley: Column Studies of Micropollutant Removal From Wastewater 
(Under the direction of Howard S. Weinberg) 
 
 Production of systems for onsite treatment of wastewater is an expanding industry 
fostering more widespread application of reuse technology. This study evaluated the potential 
for constructed wetlands to remove micropollutants from industrial and household sources and, 
thereby, reduce their environmental impact resulting from toxicity, endocrine disruption, or 
physical interaction. Their removal during conventional treatment has been extensively studied, 
yet research on the performance of biofiltration and constructed wetlands in removing 
micropollutants is scarce. 
Through a column study scale model of a constructed wetlands onsite treatment system 
and parallel batch studies, the mechanisms by which micropollutants are removed were 
explored. The removal of steroid hormones, triclosan, and caffeine in these studies was 
measured using enzyme-linked immuno-sorbent assays, and was shown to improve in the 
presence of nitrifying bacteria. Diminished removal of co-contaminants was correlated with the 
presence of triclosan, possibly due to the latter’s effect on suppression of microbial activity.  
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1. INTRODUCTION 
 
1.1 Micropollutants as Environmental Hazards 
Following the development of secondary treatment techniques for processing municipal-
scale quantities of wastewater in the early 20th century, treatment plants were widely 
implemented prompted in part by the federal mandates contained in the Water Pollution 
Control Act of 1948 (Burian et al. 2000). These greatly reduced the impact household and 
commercial effluents had on receiving surface waters in terms of biological oxygen demand 
(BOD) and nutrient enrichment, factors that significantly disrupt ecological systems (Clark et al. 
1991). Wastewater treatment has been optimized largely with regards to these parameters 
(Schmidt et al. 2003; Suarez et al. 2010). Across the world, the effluents from such treatment 
are discharged into water bodies that are often upstream of a drinking water treatment plant 
intake.  
Trace 
contaminants in sources of 
drinking water constitute 
an ongoing public health 
threat, the severity of 
which is largely unknown. 
In the 1990s concerns 
emerged regarding the 
potential effects of low 
levels of residual 
Figure 1 - Pathways of pharmaceutical residue release to the environment. 
(adapted from Heberer 2002) 
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pharmaceuticals, industrial chemicals and other biologically active compounds (BACs) in 
drinking water (Crews et al. 2000). A primary source of these contaminants is effluent 
discharged from wastewater treatment plants, which is diluted to a variable extent with surface 
water and subsequently feeds back into drinking water production, as depicted in Figure 1. 
Removal efficiencies for BACs during wastewater or drinking water treatment range from total 
elimination, or at least transformation for some, to negligible reduction for others depending on 
the chemical’s properties and the specific treatment technologies employed (Buser et al. 1999; 
Buerge et al. 2003; Ying and Kookana 2007; Cajthaml et al. 2009). 
The environmental hazard presented by these chemicals is difficult to assess. Established 
methods for quantifying biological effect have been found to be inapplicable to this problem 
because even at levels substantially lower than the minimum dose where toxicity is observed, 
endocrine disruption can produce a biological response impacting development and 
reproductive system functionality (Sumpter and Johnson 2005; Campbell et al. 2006). 
Demonstrated reproductive effects from exposure to endocrine disruptors in certain fish and 
amphibians have led to those species being considered as pollutant indicators for screening 
purposes (Hutchinson et al. 2000). However, these species are subject to highest pollutant 
exposures in wastewater treatment plant effluent and are often visibly impacted, but may not be 
sensitive to low-level exposures, and perhaps, therefore, not be predictive of impacts to other 
types of organisms (Ashby et al. 1997). Ongoing biological effects research is needed to guide 
policy and define hazardous exposure levels. At present, the only way to be certain that residual 
chemicals are not manipulating ecosystems and health would be to remove them entirely from 
the environment.  
 It becomes necessary at this point to clarify the semantics involved in this subject area. 
The term endocrine disrupting chemical, or endocrine disrupting compound (EDC) was 
commonly used during the initial emergence of concern regarding hazardous chemicals in water 
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that do not meet traditional definitions of toxicity. This would generally include any compound 
that interacts with the endocrine system, which is a signaling network within and between 
organisms. Substances called hormones secreted from glands travel to a remote receptor, which 
selectively binds the hormone and a 
response is triggered. These signals are 
integral to the timing of reproductive 
system development, but are involved in 
many non-reproductive biological functions 
as well. Disruption can take place through 
suppression of a natural signal, either by 
inhibiting the functionality of the secretion 
gland of origin or by obstructing the 
receptor binding site. Alternatively, a 
disruptor may mimic the natural hormone or provoke production by the secreting gland and 
trigger a response that would not have occurred otherwise. The various modes of interference 
are depicted in Figure 2. These mechanisms would constitute negative or positive disruption, 
defining the compound as an antagonist or agonist, respectively (Heffner and Schust, 2010). 
 
1.2 Dynamics Affecting Removal of Selected Micropollutants 
There are many different types of receptors and corresponding hormones. One such 
combination that has been studied extensively in medical literature is the estrogen system, 
which is involved in reproductive system regulation. Estrogenic effects of endocrine disruptors 
have been studied extensively in the environmental health literature; these findings are certainly 
relevant but such studies should by no means be considered comprehensive in terms of 
constraining potential for biological effects (Crisp et al. 1998). Recently, in order to avoid using 
Figure 2 – Agonism and antagonism. (McLachlan 2001) 
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overly specific terms to refer to a more general topic under consideration, the phrases 
biologically active substances (BASs) or biologically active compounds (BACs) have entered the 
common parlance to refer to potentially hazardous chemicals in the environment. Some 
researchers attempt to divide these based on original usage, such as pharmaceuticals and 
personal care products (PPCPs) as opposed to residual components of industrial process 
effluents (Daughton and Ternes 1999). This distinction is relevant to policy and regulation, but 
may not have any significance with regards to potency or metabolic pathway and mechanism of 
effect (Joss et al. 2006). All the above subclassifications fall under the umbrella term 
micropollutants due to the low concentrations (µg/L-ng/L) at which these compounds are 
typically present in the environment. 
Since research on this topic began, the specifics of how individual compounds are 
degraded and rendered inert have been investigated through a variety of approaches. 
Correlations are observed between certain treatment conditions and relatively high removal 
rates at the treatment plant level (Cajthaml et al. 2009). This provides a starting point for 
identifying specific mechanisms by which individual compounds are transformed and/or 
degraded. As stated earlier, conventional wastewater treatment plants are designed to remove 
wastewater constituents that exert oxygen demand and supply nutrients to surface water 
causing algae blooms and leading to other ecologically deleterious consequences. These include 
carbon, nitrogen, phosphorus and total dissolved solids (TDS); inactivation of pathogens is 
another primary concern. Reducing these effects requires that wastewater is treated by solids 
separation and settling, through contact with microbial populations under aerobic and 
anaerobic conditions, and exposure to a disinfectant such as ultraviolet (UV) irradiation, 
chlorine or chloramine (Joss et al. 2008). Generally speaking, compounds are subject to 
removal by chemical or physical reactivity, by microbially-catalyzed decomposition, some other 
separation mechanism, or most commonly a combination of treatments. 
5 
 
A serious concern in assessing the removal of BACs from wastewater is that they might 
not be removed during treatment but rather transformed to a daughter product that is also 
biologically active (Moriyama et al. 2004). A subset of the research generally concerned with 
occurrence of BACs has focused on their generation as disinfection byproducts during drinking 
water treatment, as a result of reaction of disinfectant with organic materials present in the 
source of drinking water production (Richardson et al. 2007). It is possible that analogous 
undesirable conversions take place during wastewater treatment resulting in equally or more 
hazardous effluent characteristics (Wu et al. 2009). Such transformation is liable to be 
undetected by traditional analytical methods that use chromatographic quantification as the 
technique is highly compound-specific. However, mass-spectrometry redeems the method in 
that it offers the capability to scan for non-targeted compounds and could allow for the 
discovery of these products. Distinguishing between transformation to equivalently hazardous 
compounds and degradation to biologically inert products is an ongoing challenge to analytical 
capacity and effective prioritizing of risk. 
Perhaps the most studied class of BACs is steroid hormones, specifically estrogens. 
Steroid hormones are organic compounds based on twenty carbon atoms arranged into four 
rings, which convey signals within the endocrine system. Estrogens are one of the five groups of 
steroid hormones, which are defined by the receptor they target. These are used to manipulate 
the endocrine system in their original capacity as birth control, fertility, and menopausal 
treatments and, therefore, it is reasonable to assume that they will be endocrine active in the 
non-targeted residual state as well (Sumpter and Johnson 2005). Due to their nearly ubiquitous 
usage and incomplete removal during conventional wastewater treatment, these hormones are 
common in wastewater treatment plant effluent as well as in effluent from onsite treatment 
systems, and in receiving surface waters (Heberer 2002; Conn et al. 2006; Kolpin et al. 2002). 
Furthermore, estrogenic steroid hormones have been found in finished drinking waters in the 
US and elsewhere (Heberer et al. 2002; Falconer 2006). 
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Biological degradation of the steroid hormones estrone (E1), estradiol (E2), depicted in 
Figure 3, the closely structurally related compound 17-α ethinylestradiol (EE2), and estriol 
(E3) during wastewater treatment has been an ongoing topic of research over the last decade 
(Cajthaml et al. 2009). Specifically, high rates of removal during wastewater treatment have 
been found to be closely correlated with exposure to aerobic environments (Froehner et al. 
2011). In general, steroid hormones were found to be 75-100% removed by exposure to 
microbial oxidation under aerobic conditions for normally practiced contact time 
durations; under anaerobic conditions, removal efficiencies suffered and less 
than 75% removal was achieved (Cajthaml et al. 2009). Removal 
rates were comparable between compounds with the exception 
of EE2, which is more persistent. Another caveat is that E1 is 
actually a daughter product produced by degradation of 
E2 (Das et al. 2004). Estradiol degradation can be 
catalyzed by physical processes such as interaction with a sorptive substrate or by microbially-
catalyzed decomposition, whereas estrone is mineralized through biotic processes exclusively. 
This dynamic can produce apparently low (even negative) removal efficiencies for estrone in the 
presence of estradiol that are in fact indicative of estradiol’s ability to add estrone to the system. 
Steroid hormones are not typically present in wastewater at concentrations that could 
support a microbiological population exclusively relying on them for a carbon source. Therefore, 
a reasonable hypothesis is that their degradation is accomplished through cometabolism, i.e. 
consumption by microbia that primarily bind other substrates (Clouzot et al. 2008). Nitrifying 
bacteria, those that participate in the oxidation of ammonia and are, therefore, also referred to 
as ammonia oxidizing bacteria (AOB), are the subset hypothesized to be primarily responsible 
for the cometabolization of steroid hormones (Yi and Harper 2007, Suarez et al. 2010). The 
process by which ammonia is transformed into gaseous nitrogen takes place in two stages: 
nitrification, in which aerobic oxidation of ammonia to nitrite and/or nitrate occurs and 
Figure 3 - Molecular structure of estradiol. 
http://itech.dickinson.edu/chemistry/?p=464 
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denitrification, which is the anaerobic mineralization of NO2- and NO3- to N2 (nitrogen gas) 
(Francis et al. 2007). AOB produce an enzyme called ammonium monooxygenase (AMO) that 
binds ammonia as well as other hypothesized metabolites. Nitrifiers’ involvement in the 
microbial degradation of steroid hormones is consistent with the observed correlation between 
high rates of removal and aerobic conditions. Additionally, specific species of AOB have been 
isolated from various media including wastewater and observed to have the capacity to degrade 
estradiol (Ke et al. 2007; Ren et al. 2007; Yoshimoto et al. 2004).  
 Another common wastewater micropollutant that has enjoyed substantial attention in 
recent decades is caffeine. Caffeine is present at much higher concentrations in untreated 
wastewater, treated effluent, and receiving waters than steroid hormones and many 
micropollutants. For this reason, combined with its solubility, exclusive origin in anthropogenic 
and specifically municipal wastes, and somewhat simpler quantification, caffeine has been 
investigated as an indicator of wastewater contamination in surface waters (Buerge et al. 2003).  
Caffeine, whose structure is shown in Figure 4, is 
primarily removed through metabolic activity of microbes. 
Specialized microbial populations dedicated to catalyzing the 
mineralization of caffeine have been discovered in soil bacteria 
isolated from coffee plantations (Dash and Gummadi 2006a) as 
well as in municipal wastewater treatment works (Ogunseitan 
2002). These species are of interest in the biotechnology 
sector for their potential to decaffeinate coffee more effectively than is possible using current 
techniques (Dash and Gummadi 2006b). In matrices where caffeine concentrations are less 
extreme it is likely that cometabolism accounts for most of its removal. Caffeine has been found 
to be efficiently removed by conventional wastewater treatment plant processes that involve 
aerobic treatment stages; for example, 81-99.99% removals were observed in Swiss wastewater 
Figure 4 - Molecular structure of caffeine. 
http://www.chemicalformula.org/caffeine 
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treatment plants (Buerge et al. 2003). Efficient treatment does not preclude readily detectable 
concentrations in surface water due to the high influent concentrations, and because losses from 
sewer systems and/or sewer overflows can contribute significantly to surface water 
micropollutant loading (Buerge et al. 2006; Joss et al. 2008). In fact, caffeine concentrations 
have been used to perform mass balance calculations that approximate losses of untreated 
wastewater from sewer systems. 
Triclosan is another common wastewater 
contaminant of concern. Used widely as an antimicrobial 
agent in soap, cleaning agents and other products, 
triclosan has been measured in wastewater in the 
hundreds of ng/L (Singer et al. 2002). The label triclosan 
is a commercial name for the chemical 2,4,4’-trichloro-
2’-hydroxydiphenyl ether, shown in Figure 5, which has 
a log Kow of 4.76, indicating that it can readily partition into non-polar phases. In surface waters 
exposed to sunlight, triclosan has been found to be converted to a structurally related type of 
dioxin, a potent toxin (Latch et al. 2003). Given that triclosan is extremely common in U.S. 
surface waters (Kolpin et al. 2002), and that up to 80% of triclosan loss may be attributable to 
photochemical transformation (Singer et al. 2002), this observation indicates that the release of 
triclosan may have serious environmental implications stemming from multiple modes of 
influence. 
As might be expected from the fact that it was manufactured as a poison to microbes, 
triclosan interacts with wastewater treatment bacteria differently from steroid hormones and 
caffeine. While roughly 80% removal of triclosan has been attributed to biotic processes during 
treatment (Singer et al. 2002), bacteria that bind with triclosan are permanently inactivated, as 
opposed to catalyzing an energy-producing reaction that is repeatable (Roh et al. 2009). 
Figure 5 - Molecular structure of triclosan. 
http://soapsmithnotes.blogspot.com/ 
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Furthermore, as with steroid hormones, activity of nitrifying bacteria has been found to 
correlate with triclosan removal and isolated AMO have demonstrated the capacity to degrade 
triclosan (Stasinakis et al. 2008). Triclosan’s biocidal properties impact AOB and while triclosan 
activity is nullified in the process, an ongoing supply of triclosan to a nitrifying system could 
result in an impaired or depressed level of functionality with regards to primary treatment 
objectives, namely nitrification (Holt et al. 2010). Given the correlations that are hypothesized 
to exist between reduction in steroid hormone concentrations throughout wastewater treatment 
and AOB described above, an inhibitory effect produced by triclosan could negatively affect 
removal efficiencies of other micropollutants, such that triclosan acts as a system input rather 
than the subject of an engineered biological process. 
 
1.3 Centralized and On-Site Wastewater Treatment 
1.3.1 Projected Increase in Implementation 
There are numerous drivers for an increasingly decentralized yet sophisticated 
wastewater treatment and management network, including growing interest in wastewater reuse 
in response to shortages in water supplies, facilitated removal of trace contaminants, and 
inadequacy of current rural treatment technology. Development of technology amenable to 
implementation in such a network is an ongoing initiative, with a limited but growing consumer 
base. 
If wastewater is to be reused onsite for non-potable purposes such as toilet flushing, 
irrigation, or cooling system water, then having to pipe that water to and from a central 
treatment facility is an unnecessarily infrastructure intensive approach. There are an abundance 
of industrial and other applications where onsite treatment and reuse were found to provide the 
most reasonable solution to issues of disposal and shortage in supply, an early example of which 
is shown as Figure 6. Especially in areas such as the southwest U.S., withdrawals of water from 
10 
 
rivers or groundwater aquifers are extremely restricted due to the scarcity of water resources, 
and so any technology that has the capacity to circumvent the conflict between users’ needs and 
in-stream minimum flow requirements is valuable. The other aspect of the arid water 
management scenario is that scarce surface water provides a lesser dilution factor for 
wastewater treatment plant effluent, which means that all else being equal, a certain dissolved 
oxygen (DO) minimum standard for the receiving water translates to a smaller volume of water 
the treatment plant can discharge. Onsite treatment and reuse, therefore, effectively solves two 
problems with one solution. 
Removal of trace contaminants, such as those previously discussed, is made considerably 
more difficult by dilution. Depending on origin and initial use, compounds that may have 
environmental health implications tend to be concentrated in certain waste streams. If those 
streams were targeted for compound-specific treatment techniques that could provide efficient 
removal prior to dilution by other wastewaters, a more drastic degree of elimination in effluent 
would be achievable (Joss et al. 2008). Additional end-of-pipe centralized polishing tertiary 
treatment such as ozonation, activated carbon filtration, and constructed wetlands coupled with 
point of generation pretreatment would cumulatively offer the best chance of lowering effluent 
concentrations of micropollutants to less than their threshold for biological activity while 
limiting the potential for ecological damage from sewer overflow and leakage (Joss et al. 2006; 
Song et al. 2009). 
Conventional rural treatment systems (currently the primary application for onsite 
treatment technology) consisting of a primary settling stage (a septic tank) coupled with a 
subsurface leachfield provide far from ideal performance with regards to micropollutant 
removal as well as control of first-order wastewater constituents carbon and nitrogen (Conn 
2006; Stanford et al. 2010). The septic tank has been in use for over a century (see Figure 6) 
and remains a central element of decentralized wastewater treatment. Essentially, wastewater is 
allowed to settle in a low energy environment resulting in separation of suspended solids and 
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buoyant scum. Outlet piping is positioned at a midpoint between the bottom of the tank and the 
static water level, so as to only permit 
clarified effluent to leave the tank. 
Periodic maintenance is required to 
dispose of accumulated solids. Removal 
of micropollutants accomplished 
through primary treatment alone is 
significant for those compounds that 
partition into the solid phase, whereas 
hydrophilic compounds that dissolve 
easily in water tend to remain in the 
effluent (Conn et al. 2006). 
The leachfield disperses 
primary effluent through a piped distribution network, from which it is released into a 
subsurface gravel bed. Flow from the leachfield into the surrounding sedimentary strata is 
dependent on the natural porosity and permeability of the soil. There is no mechanism for 
aeration or oxygen availability in such systems (aside from the minimal penetration of 
atmospheric oxygen into leachfield gravel) which is a requisite for nitrification and also to 
support microbes that catalyze the degradation of a wide variety of trace contaminants (Joss et 
al. 2004). Even if leachfield DO levels were higher in practice, the order of the anaerobic then 
aerobic environments is not conducive to vigorous nitrification and denitrification. Nitrification, 
which takes place in aerobic environments, must precede denitrification for thorough removal of 
nitrogen. Substantial impacts to receiving groundwater and surface water bodies from septic 
leachate have been documented with regards to a variety of micropollutants, and excess 
nitrogen and phosphorus have been shown to cause eutrophication and ecological destruction 
(Rudel et al. 1998, Beal et al. 2005). 
Figure 6 - "Monster" septic tank advertised in 1895. 
http://www.cefns.nau.edu/Projects/WDP/resources/History/History.htm 
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A local business has constructed a number of onsite wastewater treatment and reuse 
systems that capitalize on these opportunities for improvement. System configuration varies 
depending on application but the technology fundamentally is based on biosand filtration 
augmented by phytoremediation, configured to provide alternating aerobic/anaerobic 
environments which promote nitrogen removal. A porous substrate such as sand or gravel is 
exposed to secondary effluent containing a wide variety of microbial organisms, from which a 
biofilm is established coating the substrate media (Matamoros et al. 2007). The presence of 
plants at the substrate surface facilitates this process by increasing surface area available to 
microbes and by regulating the movement of carbon and nitrogen through the system, 
decreasing the variability of nutrient supply and buffering microbes from temporal change 
(House 2011). The contact time between flowing water and the biosand filter allows for 
microbially catalyzed removal of wastewater constituents as well as degradation and 
mineralization of hazardous compounds. This treatment approach has been found to be 
conducive to micropollutant removal through sorption and biotic mineralization, removing to a 
major extent estrogens, nonylphenol (a surfactant produced through breakdown of detergents), 
and total estrogenic activity (Stanford and Weinberg 2010). 
 This literature review prompts several questions that would clarify hypotheses 
suggested by prior research findings. Can a relationship be observed between aerobic microbial 
treatment conditions and estrogen removal? If so, is that aerobic estrogen removal 
accomplished by nitrifying bacteria? Does triclosan in wastewater inhibit the functionality of the 
nitrifying microbial cohort, and to what extent? Finally, can these phenomena be related 
through their dependence/ impact on nitrifying bacteria? 
 Given the increasingly important role of onsite treatment to prevention of 
environmental release of micropollutants anticipated for the reasons outlined above, an onsite 
context is utilized as a framework for investigation of the above questions. Prior work conducted 
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using water treated by similar systems indicates that microbial interaction with micropollutants 
is evident and measurable, meaning that these systems offer a suitable environment for 
investigation of the dynamics of these processes (Stanford and Weinberg 2010).  
 1.3.2 Emerging Regulation of Reuse Systems 
 Onsite wastewater treatment for reuse has not yet become widespread and has not been 
studied enough to spur state and federal authorities to codify design standards and guidelines 
into law. The U.S. Environmental Protection Agency (EPA) has published and updated their 
Guidelines for Water Reuse, which compiles resources, case studies, applicable regulation 
contained within legislation not ostensibly pertaining to wastewater reuse, and also state-
specific requirements (U.S. EPA 2004). In North Carolina, urban reuse is subject to quality 
requirements defined by biological oxygen demand (BOD), total suspended solids (TSS), 
ammonia content, fecal coliform (FC) count, clostridium perfringens concentration, and 
turbidity. Permitting to build systems is not standardized, and exceptions are granted by county 
public health officials on a case by case basis (House 2011). 
 
1.4 Column and Batch Study Models 
 Packed soil columns have been used in the past for a variety of modeling purposes 
including investigation of sorption and transport coefficients, partitioning and biological activity 
(Brusseau and Rao 1990). The concept is that the interaction of water with sediment can be 
replicated in a defined cross-sectional profile contained within a vertical section of tubing, 
through which water flows at a controlled rate. A compound is introduced in the water flowing 
into the column (having already wetted the packing material) and the time until breakthrough 
(the point at which the compound appears in the water exiting the column) is measured. At this 
point the capacity of the material to bind with the compound introduced is assumed to be 
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exhausted. In addition to this means of determining the extent of finite sorptive capacity, 
columns are used to test dynamic rates of change such as the ability of microbial organisms to 
transform metabolites into daughter products, or other material rates of flux (Hutchins et al. 
1984). 
Column studies as described in the previous paragraph were widely applied during the 
1990s to investigate the mechanisms controlling fate and transport of many organic compounds, 
a development commensurate with increased concern regarding the environmental implications 
of residual organics (Krzyszowaska et al. 1994.; LaPat-Polasko et al. 1994; Szabo et al. 1990). 
Having documented their affinity for the solid phase in pure solutions, some column studies 
attempted to determine the effects of matrix interactions on solubility of organic compounds. 
Iglesias-Jimenez et al. (1997) observed that exogenous organic material (humic acids, 
surfactants, and municipal compost) resulted in significantly decreased rates of sorption and 
earlier breakthrough of target chemicals in column studies. 
 Batch studies are another tested method for assessing behavior of compounds in a 
controlled experimental setting (Mansell et al. 2004). While columns employ a dynamic linear 
flow, batches contain a system in which no matter is added or removed. Contact time between 
elements within the batch results in changes in the state of the contents, which are quantified 
once the duration of the study is complete. Batch studies used in tandem with column studies 
can allow for separation of various mechanisms at work, through investigating the same 
mechanism as a process operating at equilibrium in a dynamic flow setting and as a decay 
constant in a fixed solution. 
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1.5 Chemical and Biological Measurements of Endocrine Activity 
 Two fundamentally different approaches to quantifying endocrine activity are 
commonly employed; compound-specific chemical analysis which is then related to health 
effects through toxicology work, and bioassays which expose some isolated organism or 
biologically-derived reactive component of an organism to a sample and gauge the subsequent 
degree of response. There are strengths and weaknesses to each of the techniques falling under 
either of these headings, stemming from the multitude of different potential EDCs to be 
assessed, the potential for altered effect in mixture, and the complexity of the endocrine system 
itself (Francois et al. 2003). The most commonly adopted chemical methodologies are gas 
chromatography-mass spectrometry (GC-MS) and liquid chromatography-mass spectrometry 
(LC-MS), and in bioassays the yeast estrogen screen (YES) assay has been utilized widely 
(Petrovic et al. 2004). Specificity to 
endpoint (response based on a single 
receptor type or indicator species) leads 
to false negative results if selective 
screening methods are used to 
represent entire ecosystems and 
environments. A major concern with 
chromatographic methods is that they 
are compound-selective to the point 
that a compound transformed slightly 
to a similar daughter product would no 
longer be recognized as the parent compound even though its biological effect might remain 
undiminished. On the other hand, a more comprehensive measure would offer very little insight 
into mechanism of effect. The most promising option is to use the two approaches in tandem (an 
Figure 7 - Toxicity Identification Evaluation (TIE) system for an effects-
based analysis of environmental samples (Petrovic et al. 2004) 
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example would be the Toxicity Identification Evaluation System (TIE) system, Figure 7) in 
order to eliminate the blind spots associated with each.  
 A bioassay that has been developed recently for quantification of micropollutants is the 
enzyme-linked immunosorbent assay, or ELISA. ELISA methods in general are used for rapid 
screening in medical, agricultural and food regulatory contexts. The technology is based on 
substrate-selective antibodies that bind targeted analytes, developed in animals. A fixed amount 
of these antibodies are placed in wells in a 96-well plate. Samples are allowed to react with the 
antibodies, then are removed and an aliquot of a color-linked version of the target analyte is 
introduced. Any remaining active antibody binding sites fix a molecule of the color-linked 
compound and, therefore, the intensity of color in the well is inversely related to the 
concentration of analyte in the sample. The amount of antibody binding sites dictates a 
maximum concentration that can be measured, as a calibration curve can only define a 
relationship between colorimetric response and concentration up to the point where no color-
linked analyte is able to be fixed because no active antibody binding sites remain. Application of 
this technology to wastewater is limited in the literature but detection limits, specificity and 
resistance to matrix effects, and suitability to analysis of unfiltered and unconcentrated waters 
indicate that the technique may prove superior in certain respects to established methodology 
(Nicolardi 2012). 
 
1.6 Objectives 
 The premise for research activities described in this thesis was to explore what 
processes are responsible for the elimination of micropollutants during wastewater treatment, 
their instability in wastewater and interaction with physical media, as well as how microbially-
catalyzed degradation contributes to overall pollutant removal efficiencies.  
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 In prior work where microbial effects on micropollutants have been documented, a 
common approach has been to isolate a culture of one specific organism so as to eliminate the 
complications involved in working with a consortium of microbes and allow definite conclusions 
to be drawn (Yoshimoto et al. 2004). However, this approach limits the applicability of findings 
to whole systems where ecosystems may employ fundamentally different mechanisms to 
metabolize any given compound. Therefore, a more comprehensive approach is required to 
provide more practical insight into processes at work in functioning wastewater treatment 
systems. 
 Similar weaknesses can be observed with regards to the traditional application of 
column and batch study methods to wastewater treatment. Column studies typically assess the 
physical sorptive capacity of a substrate in terms of time to breakthrough of compounds in the 
effluent after flow is initiated. This approach measures the static capacity of virgin material to 
sequester compounds, which is entirely different from the dynamic equilibrium removal 
efficiency that takes place in an operating treatment system. Batch studies are typically used to 
measure a decay rate, reduction per unit time, where there is presumed to be a mechanism of 
removal that is uniform and can be treated as comparable to a thermodynamic decay constant. 
The objective of batch studies would normally be to obtain a quantitative formula that 
characterizes this removal rate, as a function of time. 
 Using real wastewater collected on an ongoing basis, the replicability of batch 
experiments is unlikely to be consistent enough to allow a removal rate to be identified without a 
large margin of error between independent results. Furthermore, even if this rate could be 
precisely defined for the wastewater used and the exact media and microbial seeding involved, 
that formula would not be particularly relevant as it would be inapplicable to any other situation 
where the composition of the wastewater and substrate were different. Little indication of the 
contributing mechanisms would be realized, and so there would not be any basis for even 
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speculating about how pollutant removal might be expected to change in another setting, where 
the variables would be different. 
 In the experiments described in following chapters, column and batch studies were 
used in a fundamentally different way than they have usually been in the literature (Das et al. 
2004). Rather than identifying a static quantity of a compound that can be sequestered per 
volume of media (using columns) or a reduction in concentration per unit reaction time 
(through batch studies), columns and batches were allowed to reach a dynamic equilibrium 
under varying conditions, and removal efficiencies were associated with operating conditions, 
and were contrasted with one another. This comparative, and essentially qualitative basis for 
defining results makes them more generally relevant to wastewater treatment systems that vary 
in design and operation.  
 The primary objective of the research described in the following chapters is to 
demonstrate the applicability of column and batch studies towards evaluating micropollutant 
removal from wastewater. This is achieved by designing and implementing a series of columns 
that replicate the different zones of constructed wetlands treatment and together with the 
results of the batch studies, provides preliminary indications of removal mechanisms under 
conditions of dynamic equilibrium. 
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2. METHODS 
2.1 Full-scale Onsite System 
A packed soil column system was constructed that replicates the design of an onsite 
wastewater treatment system constructed at the Central Carolina Community College (CCCC) in 
Pittsboro NC. This system consists of a three-stage biofiltration technology that is supplied with 
secondary effluent, meaning wastewater that has been clarified by settling in a septic tank (see 
Appendix A). The three stages in the field system are defined primarily by their access to 
oxygen and the resulting dissolved oxygen (DO) level; there are aerobic and anaerobic stages, 
and an intermediate hypoxic stage. The aerobic and hypoxic stages are stacked, so the aerobic is 
the upper half of a raised sand filter bed with 
plants growing at the surface, and the lower half 
is made hypoxic by its removal from 
atmospheric oxygen and because it is supplied 
with untreated wastewater which has an 
elevated biological oxygen demand (BOD). The 
anaerobic element is an adjacent subsurface 
constructed wetlands, which is shallow and 
flows laterally. The biofiltration units are 
structured so untreated water enters through a 
lower manifold within the raised sand filter, at 
the top of the hypoxic stage, then flows out the 
bottom of the hypoxic element, through the 
Table 1 - Structure of CCCC onsite wastewater treatment 
system substrate. 
Layering of CCCC system substrate 
  
Aerobic stage 3" gravel 
(upper half of sand filter) 6" stalite 
 
Total height 
6" sand 
15” 
  
Hypoxic stage 6" gravel 
(lower half of sand filter) 6" stalite 
 18" sand 
 
Total height 
6" gravel 
36” 
  
Anaerobic stage 9 ¼" stalite 
(adjacent constructed 
wetlands) 
Total height 
12" gravel 
 
21 ¼” 
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anaerobic wetlands, and is pumped to a reuse tank. The aerobic stage is supplied from the reuse 
tank; this water then flows downward into the hypoxic stage and follows the same flow path as 
untreated water (Table 1). Treated water continues to cycle through the system and a reuse 
tank until it is withdrawn for onsite reuse. This cycling pattern allows for efficient nitrogen 
removal due to the alternation in oxidizing conditions, and further facilitates denitrification by 
ensuring that carbon is available during anaerobic treatment. The application rate of water to 
the hypoxic stage is approximately 3 gallons per square foot per day. Batch loading is utilized in 
the field such that the 3 gal/day is delivered in three doses timed eight hours apart. 
 
2.2 Lab-scale models 
2.2.1 Column system 
A laboratory-scale model of the CCCC system was built of stainless steel tubing and glass 
carboy reservoirs in order to avoid leaching or sorption issues associated with plastics. Three 
sections of 2” outside diameter (OD)  1/16” thick stainless steel seamLess pipe (McMaster-Carr 
of Atlanta, GA) were cut to length, and were washed thoroughly using soap, laboratory grade 
water (LGW) and rinse methanol purchased from Fisher Scientific (Pittsburgh, PA). Laboratory 
grade water (LGW) was prepared in the University of North Carolina laboratory using an in-
house Dracor (Durham, NC) water purification system from pre-filters inlet 7 MΩ deionized 
water to 1 μm, removes residual disinfectants, reduces total organic carbon to less than 0.2 mg 
C/L with an activated carbon resin, and removes ions to 18 MΩ with mixed bed ion-exchange 
resins. These columns were packed with gravel, sand and 5/16” Stalite procured 5.25.10, in 
proportions matching those of the field installation. Stalite is a lightweight, porous expanded 
slate aggregate in pea gravel size manufactured by Carolina Stalite Co. of Salisbury NC. Layers 
are formed by pouring material in from the top of the tube, tamping lightly, and measuring the 
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depth to the material surface from the top of casing. These columns were capped with aluminum 
endcaps sealed with rubber o-rings, secured using threaded stainless rods spanning the distance 
between the two endcaps on each length of pipe. A coarse aluminum mesh screen was placed 
inside the lower cap to prevent clogging of the three 1/16” ports machined into each.  
Wastewater is introduced into the top of each column through one of these ports by way 
of 1/16” OD stainless tubing that connects the columns to the preceding reservoir (Figure 8). 
Internal diameter of tubing, valves and other hardware was chosen to minimize dead volume in 
the system. Water is pumped through the tubing by pressurizing the headspace of the reservoir, 
a technique that avoids the need to filter the water as is required for mechanical pumping. This 
approach also allows fine modulation of flow rate and decreases the cost and complexity of 
system construction and maintenance. In order to allow water to flow sequentially through the 
three reservoirs and columns, a pressure gradient is applied approximating 6, 4 and 2 pounds 
per square inch (psi) in the successive reservoirs. A three way valve topping an inlet to the 
reservoir headspace can cut off flow, vent the reservoir to the atmosphere, or pressurize the 
reservoir from pressurized gas supply tanks. (See Appendix B for photos of assembled system). 
Figure 8 - Column system configuration. 
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The flow rate is further adjustable using inline needle valves after each column which regulate 
the backpressure on flow from each column to the next reservoir. Shutoff valves are used before 
each column to open or close them to the preceding reservoir. Samples were drawn from the 
outlets depicted in Figure 8, and an additional system sample was taken during each sampling 
event from Reservoir 1, through the supply line to the hypoxic column. Design consultation, 
sourcing of fittings and hardware, machining and assembly of the column system was executed 
by the University of North Carolina at Chapel Hill Environmental Sciences and Engineering 
Department’s Design Center, managed by Dr. Glenn Walters. 
The reservoirs feeding the hypoxic and anaerobic columns were pressurized using 
nitrogen, whereas the reservoir preceding the aerobic column was pressurized with air- this 
keeps DO levels close to target values similar to those produced by the field system. These 
targets were approximately <1 mg/L in the anaerobic, <2 mg/L in the hypoxic, and >2 mg/L in 
the aerobic stages. In order to further facilitate oxygen exchange going into the aerobic stage, air 
flowing into the reservoir supplying the aerobic column was introduced such that it bubbles up 
through the water before reaching the headspace. During startup, air is bled out of the hypoxic 
and anaerobic columns by pressurizing their respective source reservoirs, and opening the 
shutoff valves to allow water to flow into the columns at the top. The needle valves at the bottom 
of the columns are closed, and one of the extra ports at the top of each column is opened to the 
atmosphere. This allows air to escape as the pore space in the column media is filled with water. 
Once the water level in the column rises to meet the top cap, the bleeder port is closed, at which 
point there is no way for headspace to reopen in the column as the inlet tubing is submerged and 
only water can enter the system. DO measurements throughout column experiments are 
tabulated in Appendix C. 
The target flow rate at the field installation is 3 gallons per square foot per day, which 
corresponds to roughly 10 mL per hour through the column system (Table 2). The column 
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system flow rates are constant over 
time. The target flow rate used 
throughout the column study 
experiments was 1 L per day or 
roughly 42 mL per hour. Flow through 
each column was set the same to 
prevent reservoirs and columns from 
going dry, or accumulating excessive 
amounts of mid-treatment water in 
any single reservoir. This rate was 
necessary for logistical reasons such as 
ability to collect sample volumes in a 
reasonable span of time and to 
facilitate distribution of microbial 
colony forming units (CFUs) and 
compounds in source water 
throughout the columns rapidly upon 
startup. In the field, wastewater flows into the system during brief high flow batch loading 
events, as opposed to the constant low level flow employed in the column study. Passage of 
untreated wastewater through the system is separated from treated water cycling through by the 
timing of loading events at the upper and lower manifolds in the raised sand filter. In the 
column study, only untreated wastewater was used, with no recirculating element to the flow 
path. This means that the model system is not optimized for denitrification, as the organic 
nitrogen species that are precursors to denitrification (nitrite and nitrate) are produced in the 
aerobic stage which is last, and so they are not exposed to anaerobic treatment. Nitrite and 
Table 2 - flow rate calculations relating column system to field 
installation. 
Flow rate calculations 
 
CCCC flow rate- 3 gal/sq ft/day 
 = 3 gal/144 sq in/day 
    
Column =  3.1415 sq in 
    
CCCC area/column area = 45.83798  
3 gal / 45.83798 =  0.065448 gal/day 
  0.247747 L/day 
  247.7473 mL/day 
  10.3228 mL/hr 
  0.172047 mL/min 
    
Observed 2.17.11 – 2.18.11   
0.262 L/hr   
262 mL/hr   
25 x CCCC flow rate (approx.) 
    
Maintained during contact periods  
1 L/day   
42 mL/hr   
4 x CCCC flow rate (approx.) 
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nitrate present in the source water are likely to be converted through denitrification to nitrogen 
gas. 
These disparities are just a few of the many reasons why absolute performance level 
cannot be extrapolated from column system results to field applications. The capacity of column 
system stages to transform wastewater constituents can be compared only within column system 
results, and while the trends observed in column experiments are likely to hold true in other 
contexts, the quantitative measures of performance do not directly translate. Given that the field 
system flow rate is lower by a factor of approximately 4, it is reasonable to hypothesize that the 
increased contact time may result in higher removal efficiencies for a given initial concentration.  
Another fundamental difference between the model system and the field installation is 
the configuration of the anaerobic stage. At CCCC, wastewater enters a side of the subsurface 
constructed wetlands and flows laterally, meaning that the vertical reconstruction of substrate 
that constitutes the anaerobic stage in the column system did not accurately reproduce the 
contact time and surficial interaction that takes place in the field. This difference indicates that 
the column system will tend to underestimate the capacity of the field installation’s anaerobic 
phase to effect transformation and reduction of wastewater constituent concentrations and will 
underexpress the physical sorptive capacity of that treatment stage. Significant logistical issues 
would be involved in the construction and operation of a scale model of the actual spatial 
behavior in effect at the field installation.  
The column system is fundamentally used to explore the correlation between oxygen 
availability and treatment characteristics, and so exact reproduction of CCCC dynamics is not a 
priority. Basing the column structure on a field system provides environmental relevance and a 
frame of reference, but does not dictate configuration or operational parameters.  
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2.2.2 Batch studies 
Batch studies were utilized to further identify the relative importance of each of the 
various elements of treatment (physical sorption, microbial transformation, compound 
instability) in an aerobic context. 500mL Erlenmeyer flasks were filled with substrate identical 
in proportion to that used to pack the aerobic column, but half the total volume so as to not 
overfill the container. 250mL of CCCC wastewater was added to establish a biofilm on the 
media; this mixture was maintained on a shaker, capped, at 175 revolutions per minute (RPM) 
for 2 weeks at 20° C. Following this acclimatization period the liquid was discarded and replaced 
by 250 mL fresh wastewater which was exposed to the biofilm under the same conditions for 
five days contact time, after which the water was sampled for analysis. Samples from batches 
filled with active wastewater were compared with those from batches that were autoclaved 
(substrate autoclaved after acclimatization, immediately prior to being refilled with autoclaved 
wastewater), and with batches that had been spiked with AMO inhibitor allylthiourea purchased 
from Fisher Scientific (Pittsburgh, PA) to observe to what extent target chemical removals 
increased in the presence of active microbial populations, including and not including the 
nitrifying subset. 
In addition to quantifying the effect of inhibited batches compared with non-inhibited, 
iterations were conducted wherein target chemical concentrations were elevated, compared with 
simultaneously conducted batch studies using unspiked wastewater where target chemicals were 
present at background levels. A second variation involved spiking the treatment group with 
triclosan in lieu of allylthiourea, to test for its hypothesized inhibitory effect on nitrification and 
potentially, its indirect effect on steroid hormone removal.  
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2.3 Inhibition of nitrification 
Allylthiourea (C4H8N2S) is a selective, effective inhibitor of ammonia oxidizing bacteria 
that has been used to conduct respirometric experiments to quantify nitrification rate based on 
oxygen consumption for more than 50 years (Hofman and Lees 1953). It has been demonstrated 
to permanently and completely block ammonia oxidation at a concentration of 86 µM (Ginestet 
et al. 1998). It is one of several compounds demonstrated to be capable of inhibiting 
nitrification. The nitrogen anion azide (N3-) sometimes used bound to a potassium cation (KN3), 
in addition to blocking oxidation of ammonia to nitrite, also inhibits the remainder of the 
ammonia to the nitrogen gas transformation process (Bremner and Yeomans 1986). Chlorate is 
an AOB inhibitor but has been observed to be less specific and less instantaneous in effect than 
allylthiourea (Belser and Mays 1980). Nitropyrin, known as N-serve, is a similar inhibitor that is 
commonly used in agricultural applications to prevent oxidation of ammonia to nitrite and 
nitrate because these species are soluble (Lewis and Stefanson 1975). Nitrogen in fertilizer is 
prone to leaving the field in oxidized form in groundwater and runoff, in addition to biologically-
catalyzed denitrification and volatilization. Allylthiourea was selected for this research to 
differentiate analyte transformations catalyzed by nitrifying bacteria from that of the microbial 
population at large because of its superior selectivity and the complete effect it has been 
demonstrated to have in nitrifying bacterial cultures (Ginestet et al. 1998). 
The literature defines allylthiourea as a permanent inhibitor of nitrification, meaning 
that microorganisms that bind with the compound do not recover. Even so, over time if 
microbially active wastewater containing no inhibitor continued to flow through a column that 
had been treated with allylthiourea, it is inevitable that at some point the dose of inhibitor would 
be exhausted and nitrification would resume. This approach is preferred to resetting the 
columns by repacking with fresh materials, because changes, consequential to disturbing system 
dynamics and reestablishing a new microbial population from a wastewater that will inevitably 
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be of different constitution, are avoided. It is unlikely that the viability of this option can be 
predicted from results published in the literature as the outcome is highly dependent on 
situational variables specific to this column study such as flow rate, type of substrate, makeup of 
wastewater, etc. Therefore, a trial is necessary to determine how to prepare the columns for a 
new iteration of sampling after they have been exposed to chemical manipulation. See 
Appendix D for information on quantification of nitrogen species. 
 
2.4 Source water 
Collecting wastewater from CCCC 
to use as source water in the column and 
batch studies was a low-tech affair. 
Following primary treatment by septic 
tank, secondary effluent flows into a 
pump tank from which it is transferred to 
the treatment system. This tank is 
accessible by a manhole cover secured 
with screws. Using a 1 L polyethylene 
(PE) bottle on a string, which is hose-
clamped to a metal weight to cause it 
to submerge easily, water was bailed 
multiple times from this pump tank in 
which the water level is roughly 15’ 
below the ground surface (Figures 9, 
10 and 11). The contents of this bottle were transferred to a glass carboy or 19 L PE container 
for the return trip to the UNC laboratories. The DO level in this tank was measured at 0.26 
Figure 10 - Wastewater sampling equipment. 
Figure 9 - CCCC onsite system pump tank. 
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mg/L using a DO probe, which suggests conditions in the tank are anaerobic due to the high 
BOD of the wastewater. 
Daily variability in source 
water composition and quality 
presents a source of error that is 
difficult to control. The student 
population at CCCC fluctuates so 
that usage patterns and dilution 
factors, as well as the 
concentrations of various 
constituents and micropollutants, 
are all in a constant state of flux. 
One option would be to sample a large batch of water at one time and store it, in order to obtain 
a consistent matrix for all iterations of batch and column experiments. However, stabilization of 
this stored water is extremely problematic. Aside from settling and physical separation, 
microbial action could result in significant changes in total organic carbon (TOC), nitrogen, and 
also trace constituents. Additionally, the microbial population extant in the wastewater matrix 
would be certain to shift and affect what subsets remained to seed the column and batch 
substrate and, therefore, the treatment that population could offer. Any removal of bacteria or 
other microorganisms from water introduced to experimental substrate could potentially have 
drastic consequences to results and so attempting to chemically, thermally, or otherwise 
suspend activity in the wastewater matrix during storage is too risky a proposition. The favored 
alternative is to repeatedly withdraw fresh wastewater for each round of experiments and 
characterize results relative to the contemporaneous source water. This introduces co-varying 
factors that lead to noise and error in results, but this approach is less fundamentally flawed in 
that the matrix and the constitution of the treatment system in practice is preserved. 
Figure 11 - CCCC pump tank with treatment system in background. 
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2.5 Nomenclature for column system and batch study samples 
 A naming systematic was employed for samples generated by column and batch studies 
allowing for determination of order and system conditions. As an example, for the sample 
identification code: 
𝑩𝟐. 𝟑 𝑼𝑺 − 𝟏 
B identifies which of the series of sampling events the sample was taken during, 2 specifies 
which reservoir, column or batch the sample came from, and 3 further defines which subseries 
the sample belongs to if more than one set of samples was taken for the same series. A series 
generally relates to an operational variable having been changed, the effect of which is assessed 
by taking one or more sets of samples that in theory should be characteristic of the operational 
parameters in place at the time.  
 Column system sampling series were labeled by letter starting with “A” and proceeding 
consecutively. The first batch study series was labeled “Z” and subsequent iterations have been 
labeled moving backwards through the alphabet. With column system samples, the numbers are 
consecutive such that 1 corresponds to source water drawn from Reservoir 1, 2 comes from the 
outlet of the first column (hypoxic), 3 is taken following the second column (anaerobic), and 4 is 
taken following the third column, which is aerobic. Batch study numbers are correlated with 
treatments by a key, for each series. Most sampling series had only one set, so where no decimal 
place and sub-series number are included, it can be assumed that the sample is from sub-series 1 
of 1. The term BX.3 would refer to all stages within the B-series from the third set, and has the 
same meaning as B1-4.3, both encompassing B1.3, B2.3, B3.3 and B4.3. 
 The part of the sample code after a space was appended to track subdivision of the 
same sample. For certain experiments aliquots of the same sample were taken and used for 
standard addition or quality control purposes. These were labeled US (unspiked), Cal 
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(calibration point), or N for nitrogen quantification, and numbers were used as needed to 
distinguish multiple aliquots taken for similar uses. Where no label was appended of this type, 
no subdivision was made and the sample may be considered 1 of 1.  
 
2.6 Experimental timeline 
 2.6.1 Column study samples 
Column study experimental procedure was as follows. Construction of the column system was 
completed 1.17.11, and it was pressure tested and checked to confirm that all connections were 
fully sealed. It was then packed with materials as described in the preceding section, and flow 
through the system was tested using LGW. When this water flowed through the columns and 
associated plumbing without clogging or excessive backpressure, primary effluent withdrawn 
from CCCC on 2.16.11 was introduced to the system and biofilm was established on the column 
media over a period of two weeks. Filter plate methods were initially employed to assess the 
degree to which biomass had accumulated within the column system, but their use was 
discontinued due to ambiguity regarding whether the measurements obtained could reasonably 
be expected to correlate with experimental parameters. For discussion of filter plate methods, 
refer to Appendix E. 
In order to more rapidly saturate the column substrate with microbial CFUs, a 20L 
carboy filled with media (Stalite, sand and gravel in proportions identical to those of the aerobic 
column) was saturated with wastewater in aerobic conditions. A manifold distributed 
pressurized air to multiple frits submerged in a mix of substrate and wastewater; this setup was 
maintained for two weeks at 20° C. The carboy then took the place of the empty Reservoir 1, in 
order to distribute this presumably highly biologically active water throughout the columns. The 
headspace pressures applied at that time within the successive reservoirs were 8, 6 and 4 psi. On 
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2.25.11, the pressures in the carboy serving as Reservoir 1 reached the point at which the 
container exploded. In order to prevent a reoccurrence, headspace pressures in the reservoirs 
were dropped to 6, 4 and 2, a plywood platform was constructed to ensure that the base of the 
reservoirs were evenly supported, substrate was not used in reservoirs again, and blow-off valves 
were installed on the headspace outlet of each reservoir. 
After system startup on 2.16.11 followed by an acclimatization period of two weeks, A-
series samples were collected on 3.2.11. These were to provide an indication of baseline 
concentrations of analytes in source water, and to provide an indication of overall removal rates 
in order to choose dilution factors going forward. The aerobic column was uncapped to allow gas 
exchange with the atmosphere (Figure 12). Following column system tweaks, additional 
samples (B-series) were taken on 3.17.11. 
The column system was immediately thereafter refilled with source water spiked with 
estradiol, caffeine, triclosan, ibuprofen, nonylphenol, and estrone at 2 µg/L above the 
background level (see Appendix F). C-series samples were taken after a one week contact time, 
on 3.24.11. B and C series samples were quantified. On 3.25.11, allylthiourea was added to 
unspiked source water that was used to refill the column system, at a concentration of 10 mM or 
1.16 g/l. The media was not changed. D-series samples were taken for analysis by Hach kits for 
ammonia, nitrite, and nitrate concentrations starting on 4.28.11 and repeating 7 more times 
through 5.16.11 (data included as Appendix D). It was determined through these tests that 
nitrification was not resuming over this time period as nitrite and nitrate concentrations did not 
show an increasingly upward trend through subsequent system samples over time, and 
ammonia concentrations did not show an increasingly downward trend. D-series samples for 
solid phase extraction (SPE) were taken 4.28.11. 
The column system was completely emptied, washed with Alconox, LGW and methanol, 
repacked with fresh substrate and reestablished flowing unspiked source water on 5.25.11. The 
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system was operated at roughly 2.5 L/day 
until 6.1.11 in order to more quickly 
distribute microorganisms throughout the 
system, ensure availability of nutrients, 
and rapidly acclimatize the columns and 
establish a biofilm. On 6.1.11 Reservoir 1 
was refilled with source water containing 
spikes of estrone, estradiol, caffeine and 
ibuprofen, increasing the background levels of 
those chemicals by 1 µg/L. Nonylphenol was not added because by this point, it had become 
clear that the analytical techniques used to quantify nonylphenol were going to be inapplicable 
to this wastewater matrix. Triclosan levels were not elevated to avoid its hypothesized inhibitory 
effect on microbial action within an experimental series not designed to measure this effect. E-
series samples were collected 6.6.11. These were the first samples to be analyzed for estradiol, 
caffeine, and triclosan. Stock compounds were purchased from Fisher Scientific (Pittsburgh, 
PA). It was determined using these analyses that all compounds were detectable throughout 
treatment stages without being artificially elevated, so unspiked water was subsequently used to 
refill reservoirs. F-series samples were collected in two staggered sampling events, F1-4.1, and 
F1-4.2. On 7.7.11 system samples were taken derived from what based on flow rates and column 
volume was assumed to be an unspiked system (F1-4.1). The system was then immediately 
refilled with source water spiked with allylthiourea, again at 10 mM. After a 5 day contact time, 
inhibited column system samples were collected (F1-4.2). 
The final sampling event investigated triclosan’s hypothesized inhibition of nitrification. 
Following the F-series sampling event, the column system was broken down, old substrate was 
discarded and the system repacked, reestablished and reacclimatized by flowing fresh 
wastewater for two weeks. On 8.3.11, the first of the two G-series system sample sets were taken 
Figure 12 - Aerobic column uncapped to convert to 
unsaturated flow. 
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(G1-4.1). Each reservoir was then spiked with 10 µg/L triclosan, elevating the concentration 
above background levels. The system was run for 5 days, and G1-4.2 system samples were taken 
on 8.8.11. 
2.6.2 Batch study samples 
The first batch study series was initiated on 5.25.11. Unspiked wastewater was added to 6 
batches of substrate (as described in section 2.2.2) which were acclimatized for one week. On 
6.1.11 liquid was decanted, and two batches were autoclaved. All were then refilled, three with 
unspiked source water and three with source water containing spikes of estradiol, caffeine, 
ibuprofen and estrone at 1 µg/L. One of each set was an autoclaved batch; water added to that 
flask was separately autoclaved, before additions. These six batches were maintained on a 
shaker at 20° C for a five day contact time, and autoclaved in their flasks for 60 minutes at 110 
°C and then stored at room temperature. Autoclaving was the sole aseptic technique employed 
to ensure sterility. Active aliquots of source water were also set aside off the shaker to assess 
baseline decay and microbial activity. The supernatant from these batches was decanted and 
sampled on 6.6.11, sample designations Z1-8. This batch series aligns with column system 
sample series E in treatment and control type, and were conducted simultaneously using the 
same source water. 
Similarly, batch series Y lines up with column system sample series F in that three 
batches spiked with allylthiourea are compared with three control batches, one of each set being 
autoclaved. Again autoclaved and active aliquots not in contact with batch media were 
maintained off the shaker. Acclimatization was initiated on 6.22.11, and contact time was from 
7.7.11 until 7.13.11. The final batch study was allowed to acclimatize from 7.22.11 until 8.3.11, 
then was spiked with 10 µg/L triclosan for the treatment set, and an unspiked control set was 
maintained alongside on the shaker. The batches were sampled on 8.8.11, and correspond to the 
column system G-series samples.  
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2.7 Sample analysis 
 2.7.1 Gas chromatography-mass spectrometry (GC-MS) 
The approach initially taken for the analysis of wastewater for trace organic 
contaminants involved methods based on 
solid phase extraction (SPE) coupled with 
gas chromatographic separation and mass 
spectrometric detection (GC-MS) (Stanford 
and Weinberg 2007). This technique was 
attempted to analyze column and batch 
study samples, with mixed results. The SPE 
procedure allows for concentration of some 
analytes and elimination of other highly polar or high molecular weight wastewater constituents 
that would otherwise cause high background noise, obscuring the chromatographic signal. This 
method has been demonstrated to allow for detection limits in the 0-10 ng/L range in the source 
wastewater, corresponding to 10-100 µg/L in the final extract, assuming 100 percent recovery 
(Stanford and Weinberg 2007). 
Prior to extraction, 500mL liquid samples are filtered using 2.7, 1.5 and 0.45 µm pore size glass 
fiber filters in sequence. Glass fiber filters were purchased from Fisher Scientific (Pittsburgh, 
PA). Filtrate is then drawn through 500mg/3 mL Strata SAX (strong anion exchange) and 
200mg/6 mL Strata X sorbent cartridges (Phenomenex, Torrance, CA) in series at a flow rate 
not exceeding 8 mL/min, stacked on a Supelco 12-port vacuum manifold (Sigma-Aldrich, St. 
Louis, MO) as shown in Figure 13. These cartridges are preconditioned using a series of 
solvents to activate the selective chemical reactivity of the absorbant material as called for by the 
manufacturer’s literature. The SAX is used as a pretreatment to remove anionic co-
contaminants prior to extraction of analytes onto the Strata X. Following extraction, the SAX 
Figure 13 - SPE using Phenomenex cartridges on a Supelco 
vacuum manifold. 
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cartridge is removed and the retained analytes are eluted from the Strata X cartridge into a 25 
mL conical vial using 5 mL of a mixture of methyl tert-butyl ether (MtBE) and methanol, 
purchased from Fisher Scientific (Pittsburgh, PA), in equal proportions. A 200mg/3mL Strata 
Si-1 cartridge was placed inline after the Strata X during elution to further eliminate co-
contaminants from the eluate by selectively sequestering polar compounds. The glass vials were 
placed on a heating block at 40 ◦C and the extracts blown down to dryness under a gentle flow of 
nitrogen gas using a Pierce (Rockford, IL, USA) Reacti-Vap Model 18780. The extracts are 
blown down to dryness in order to allow for derivatization, which caps hydroxyl groups on polar 
analytes in the extract. 50 µL bis(trimethylsilyl)-trifluoroacetamide (BSTFA) + 1% trimethyl-
chlorosilane (TMCS) and 50 µL pyridine, a catalyst (purchased from Fisher Scientific in 
Pittsburgh, PA), are added to the dried extract. It is essential that no water or methanol be 
present for this process to be successful. The reaction is facilitated by vortexing and heat (65° C 
for 35 minutes), then quenched using 100 µL LGW to avoid introducing excess derivatizing 
agent to the GC column where it could cause damage. 100 µL hexane is then added to the 
mixture and the vial is vortexed to ensure analyte transfer. The hexane is drawn off using a 
Pasteur pipette and stored in a 1 mL autosampler vial to be analyzed by GC-MS. This extraction 
process yields a 5000-fold concentration factor assuming 100% analyte recovery. The technique 
described above is based on method development by Stanford and Weinberg (2007).  
A Varian 3800 GC and Saturn ion trap MS with an internal ionization source (Varian 
Inc., Walnut Creek, CA) was used to analyze sample extracts. A Varian Factor Four DB-1 MS 
column (30 m x 0.25 mm ID x 0.25 µm film thickness) with integrated 5 m guard column was 
employed to separate analytes, with 99.999% helium as a carrier gas at 1.5 mL/minute. An oven 
temperature program was used that increased the temperature from an initial 60° C to 290° C 
over a period of 33 minutes total. Hexachlorobenzene (HCB) was used as a performance 
standard to quantify variation in instrumental sensitivity. Areas of chromatographic peaks 
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identified as representing the various analytes by virtue of having a retention time identical to 
that observed for the pure derivatized standard were used to quantify concentration by 
comparing the peak area relative to HCB measured simultaneously by instrumental response to 
known concentrations. Identification of a peak as representing a particular compound can be 
confirmed by analyzing the mass spectra for ions eluting at that retention time to determine 
whether they are characteristic of that compound. 
The established GC-MS sample workup procedure described above proved difficult to 
adapt to samples produced in the course of this research project due to elevated levels of 
dissolved organic matter (DOM) in the extracts. High levels of suspended solids and dissolved 
carbon and nitrogen in high-strength wastewater present a challenge to filtration and extraction, 
in that active sites in sorbent media are exhausted quickly. Breakthrough and clogging became 
problematic (Figure 14). If the SAX cartridges are allowed to become compromised not only 
does the flow drop to an unusable slow rate, but breakthrough occurs into the Strata X (Figure 
15). This imparts a visually apparent coloration to the extracts post-elution, which indicates that 
they are unusable for GC analysis because the background noise would be too high and 
potentially damaging to the instrument (Figure 16). An alternative is to exchange SAX 
cartridges that are approaching saturation for fresh ones, without using a different Strata X 
cartridge. While this does allow for an extract that has not been compromised by excess co-
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contaminants, the extraction efficiency is not uniform resulting in inconsistent recovery of 
standard addition.  
Centrifuging, and an additional 0.2 
micron filtration step were explored as means 
of additional pretreatment to improve SPE 
recovery. 40 mL vials were used for 
centrifuging, requiring that a 500 mL sample 
be distributed among thirteen vials, and that an 
additional 3 be filled with LGW to evenly 
weight the centrifuge rotor and avoid 
imbalance (Figure 17). 30 minutes at 1000 
RPM (the upper limit possible using glass vials 
of this size without breakage) produced some 
separation of materials such that the 
supernatant from each vial could be poured off 
and recombined in a single sample flask. This 
step was found to have a negligible effect on 
filtration speed and ability to pass the sample 
through SAX. Additionally, the significant 
contact with additional glassware and loss of 
sample to handling detracts from extraction 
efficiency and complicated sample workup. 
Centrifuging, at least under these parameters 
was not found to enhance the SPE process. The 
filtration step likewise was not found to make a 
Figure 15 - Compromised Strata SAX cartridges and 
breakthrough to Strata X, 3.9.11 
Figure 16 - Extracts compromised by Strata SAX 
breakthrough. 
Figure 14 - Exhausted SAX cartridges and breakthrough to 
Strata X, 2.28.11. 
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noticeable difference in ease of extraction, and added to sample workup time and loss of sample 
and analyte to the filter paper. 
Even if workarounds are developed to the 
immediate issues that physically preclude SPE, 
elimination of particulate and dissolved content 
(mandated by instrumental tolerances) also 
removes an unpredictable fraction of target 
analytes from the matrix. Two of the target 
compounds, estradiol and triclosan, are 
hydrophobic and partition into organic phases, 
which would initially seem incongruous with their 
environmental behavior, where they have been observed to be relatively persistent in surface 
waters. Figure 18 depicts mechanisms of environmental transport or sequestration; while 
hydrophobic target compounds would be 
expected to be incorporated into 
sediment, in practice they tend to remain 
entrained in the water column. Estradiol 
and triclosan are also found in effluent 
from wastewater treatment plants having 
undergone contact time with activated 
sludge, in a conventional wastewater 
treatment context. One explanation is that dissolved and particulate organic matter in surface 
water and wastewater interacts with these compounds and forms a complex that is stable in an 
aqueous matrix (Stanford et al. 2010). This basic concept has been demonstrated with regards to 
other micropollutants such as pesticides (Iglesias-Jimenez et al. 1997) and more recently with 
Figure 18 - Transformation and fate of micropollutants in surface 
waters (Birkett and Lester 2003). 
Figure 17 - Centrifuge and sample distributed into 40mL vials. 
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estradiol (Casey et al. 2003, Das et al. 2004). The fate of these analytes will, therefore, be closely 
linked with that of organic matter. 
Given that organic matter is removed during sample workup for GC-MS, by filtration and 
then by Strata SAX pretreatment, variation in extraction efficiency and loss of analyte along with 
screened-out carbon is likely to correlate to a certain degree with experimental variables, 
because more treated or more diluted samples have lower concentrations of particulate and 
dissolved content. Therefore, significant bias is intrinsically associated with these analytical 
techniques for dense matrices. 
2.7.2 Abraxis ELISA 
Abraxis, an immunochemistry products manufacturer in Warminster, PA has developed 
enzyme linked immune-sorbent assays (ELISA) kits for rapid measurement of selected 
micropollutants in water. Estradiol, caffeine, and triclosan were quantified using individual kits. 
See Appendix G for Abraxis instructions on conducting analysis using their ELISA materials. 
The general procedure is as follows. 50 µL of standard solutions (6 for estradiol and 
caffeine, 7 for triclosan, all provided with Abraxis kits) are transferred by pipette into wells 
containing an antibody layer in the 
bottom. Duplicate wells are used for 
each standard or sample. 50 µL of 
sample is transferred by pipette into 
subsequent wells. 50 µL of antibody 
solution is then added, the wells are 
covered and the mixture is agitated, and 
a 30 minute incubation period is 
undergone at room temperature. At that point, 50 µL of an enzyme conjugate solution is added, 
Figure 19 - Addition of enzyme conjugate to wells. 
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the mixture is covered and again agitated, 
and an incubation period takes place, the 
length of which varies from kit to kit 
(Figure 19). The wells are then washed, 
which involves emptying the contents out 
and rinsing with a wash solution (included 
in kit materials). Following the wash step, 
a color solution is added (the volume of 
which depends on kit-specific directions) 
and 20 minutes incubation at room 
temperature are allowed.  The colorimetric 
response to analyte concentration is visible 
at this point- intensity of color is inversely 
proportional to concentration of target 
chemical in the sample (Figure 20). A 
stopping solution is then added to each well 
(varying volume) and the plate is ready to be measured (Figure 21). 
Measurement is performed using a plate reader set to measure absorbance at 450 nm. 15 
minutes is the time limit defined by Abraxis literature within which the plate must be read, after 
addition of the stopping solution. The plate reader automatically zeros the detector response 
prior to every reading. Absorbance readings fall between 1.6 and 0.2 absorbance units (AU), 
with triclosan kits producing the highest absorbance range, and caffeine producing the lowest. 
The Abraxis ELISA approach circumvents the problems described for SPE in that no 
sample filtration or concentration is required. On the contrary, the sensitivity of the Abraxis kits 
is such that samples had to be substantially diluted to produce results that fall within the 
Figure 20 - Response visible after addition of color solution. 
Figure 21 - Final color is yellow following addition of stopping 
solution. 
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calibration range. Dilution constitutes a complicating factor to a certain extent because the 
approximate concentration of a sample must be known prior to analysis in order to avoid 
outlying results. Also, error is compounded by correction for dilution, to a degree that varies 
from sample to sample depending on dilution factor. Initial work focused on determining what 
dilution factors were appropriate for the various sample types involved in this research. Dilution 
factors ranged from 5- to 20-fold for wastewater treatment system samples, depending on 
degree of treatment and whether any spikes were made. Discussion of additional considerations 
involved in the application of Abraxis kits to wastewater samples is included as Appendix H. 
 2.7.3 Quantification using GraphPad Prism 
 As preparation for 
performance of ELISA analysis 
using Abraxis kits, a diagram 
illustrating sample layout was 
drawn up. As an example, the 
diagram for an E2 kit used on 
6.6.11 is included as Figure 22. 
Once the execution of the assay is 
complete, plate well absorbances 
are measured using a plate reader. 
The output of the plate reader 
presents values in a similar grid 
format based on well location; an 
example is included as Figure 23, 
from the same analysis and plate as described in Figure 22. Standard curve wells were 
designated as such in the template prior to reading the plate, and so are marked by a different 
Figure 22 - Diagram illustrating sample layout during estradiol analysis 
6.6.11. 
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background color. Layout diagrams and plate 
reader printouts have been compiled in a binder for 
reference, along with Abraxis kit documentation 
(Appendix G).  
 To interpolate concentration from 
absorbance values, the standard concentrations 
and sample absorbance data were entered into 
GraphPad (San Diego, CA) and a standard curve 
produced (Figure 24). Concentrations are then 
converted into log values, which causes the 
generation of a sigmoidal curve, when 
log(concentration) vs. absorbance is plotted 
(Figure 25). A “dose response – variable slope” 
curve is then fit to the data, for which the formula is proprietary to GraphPad and not provided 
to the user (Figure 26). The software used by Abraxis is also proprietary; a comparison of 
results produced by the two different algorithms shows that while the curves are different, the 
final results produced were very similar. This curve fit is identified in GraphPad literature as 
being comparable to the “four-parameter logistic curve” utilized by Abraxis. From a dose-
Figure 23 - Plate reader reading from estradiol analysis on 
6.6.11. 
Figure 24 - Untransformed E2 standard curve data 
from Figure 23 entered into GraphPad. 
Figure 25 - Log-transformed E2 calibration curve points, 
from data in Figure 23. 
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response curve, analyte concentrations in samples can be interpolated based on their 
absorbance readings (Figure 27).  
 It was discovered that in cases where 
GraphPad discards as outliers some sample 
readings that were in fact within the calibration 
curve, it is possible to fit a “dose response – 
normal slope” curve, which corresponds to a 
three-parameter curve in other programs, and 
thereby produce interpolations for those marginal 
results. R2 values decline slightly, but not to the 
extent that accuracy is significantly compromised. 
This curve fit was utilized for some results, identified as they are presented. Output is in terms of 
log-transformed concentration, the anti-log of which is the non-dilution corrected concentration 
of the sample. 
 
Figure 27 - Normalized absorbance readings used to interpolate concentration of 7 E-series samples. 
  
Figure 26 - Normalized standard curve with dose-
response (variable slope) curve fit for data in Figure 25 
using GraphPad software (R2 = 0.9456). 
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3. RESULTS AND DISCUSSION 
 
3.1 A, B, C and D column study sample series 
 Before Abraxis materials were secured for the analysis of wastewater samples for all 
three analytes (description to follow), several preliminary series of analyses were completed.  
 A-series samples were taken 3.2.11, consisting of a single sample of source water 
collected from Reservoir 1 (See Figure 8), which was subdivided into three aliquots, two of 
which were spiked with target analytes at varying levels to assess recovery and validate 
analytical methods on 3.8.11 and 3.9.11. The difficulties described previously with suspended 
and dissolved organic content precluded quantification of these extracts by SPE and GC-MS 
due to high background co-contaminant levels, to the point of being visible in the SPE 
cartridges (Figure 14). On 3.8.11 the aerobic column was converted to unsaturated flow in 
order to more closely simulate the field installation and facilitate aerobic treatment. B-series 
column system samples were taken 3.17.11, encompassing all four stages of treatment (B1-
B4). Standard addition was used to assess recovery, splitting each sample into three 
aliquots: one unspiked (US-1), and two spiked at different concentrations (Cal-1 and Cal-2).  
 That same day, 2 µg/L of each of 6 target analytes were spiked into the source water, to 
elevate their baseline concentration in Reservoir 1. On 3.24.11, C-series system samples were 
collected across all four stages of treatment. D-series samples were taken with the intention 
of quantifying rebound of nitrification after inhibition. 
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 3.1.1 Dissolved oxygen 
   DO values throughout B and C-series experiments are presented as Table 3.  
Table 3 - DO (mg/L) in column system. 
Date Reservoir 1 Hypoxic Anaerobic Aerobic 
2.16.11 2.75 2.95 4.98 5.10 
2.21.11 2.58 2.35 1.85 2.15 
3.2.11 0.98 3.41 1.65 3.04 
 
 3.1.2 Discussion of column system DO levels 
Disruption was observed to be a major factor determining DO levels in the column 
system. DO concentrations follow a general pattern of decreasing until the aerobic column, 
where a significant upward shift is observed (Table 3). This is a product of the system’s design; 
headspace is pressurized with nitrogen in the first two reservoirs in order to eliminate 
replenishment of DO by exchange with the atmosphere. Without oxygen input, BOD was 
anticipated to bring about anoxia in the first two reservoirs and, therefore, in the first two 
columns, which are supplied from those reservoirs as would occur in the field installation. 
However, tasks such as refilling the first reservoir with source water, spiking in compounds 
related to experimental objectives, and taking system samples required that the reservoirs be 
periodically depressurized, which allowed air to enter the headspace. A correlation between 
sampling activities and elevated DO readings was observed on a number of occasions. Because 
nitrogen is less dense than oxygen, any oxygen that enters the system is likely to settle to the 
liquid-gas interface and exchange is thereby facilitated. To address this issue, sparging with 
pressurized nitrogen was employed prior to resealing and repressurizing the reservoirs. The 
aforementioned density considerations complicated this process since displacing oxygen with 
nitrogen was only possible in a transient sense. First, a nitrogen supply line was taken loose and 
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manually passed around the inside of the reservoir, attempting to wash oxygen towards the 
opening. The reservoir stopper was then replaced quickly, and the reservoir repressurized to at 
least 3 psi. The flow from the gas tank was then shut off, and the valve that vents headspace gas 
to the atmosphere was opened to allow headspace pressure to blow off. When gas flow tapered 
off and equilibrium nearly reached (as assessed from the sound of escaping gas), the valve was 
closed and the headspace was again pressurized from the gas tank, to its operating pressure. 
This procedure was unlikely to completely eliminate oxygen from the gaseous mixture inside the 
reservoirs, but it was reduced as effectively as possible. While BOD will return DO levels to their 
targets given an equilibration period, the microbial activity involved in this process may have 
resulted in transformations to wastewater that are not associated with the oxidizing 
environment the columns were meant to represent, except in the instance of the aerobic column 
where exchange with atmospheric oxygen was expected. 
 During ongoing column operation and experimental utilization, an alternative gas 
could have been used to ameliorate these logistical concerns. Anything heavier than oxygen 
would separate air in the headspace from the liquid, making complete elimination of gas 
contamination unnecessary. Another consideration is that during denitrification, dissolved 
nitrite and nitrate are converted to nitrogen gas, a process that could potentially be retarded by 
the presence of a pressurized gaseous phase already dominated by nitrogen. While the metabolic 
processes and environmental tolerance of specific microbial species involved would determine 
the extent to which this is a factor, it is conceivable that elevated levels of nitrogen gas could 
prevent the reaction from proceeding. Further discussion of denitrification follows below. The 
noble gas argon merits consideration as a replacement; its density, lack of reactivity or 
involvement in any of the common transformations typical of wastewater treatment, and 
common availability due to its use in welding indicate that it is likely to prove suitable. 
 
47 
 
3.1.3 Analysis of B and C-series samples 
 Abraxis representative David Deardorff conducted a training session on using Abraxis 
ELISA kits 3.28.11. Samples had been collected after operation of the column system for one 
week using wastewater spiked with 2.0 µg/L each of six target species including E2 (see section 
2.6.1). For purposes of demonstration, C4 US-1 filtered and C4 US-1 unfiltered were analyzed for 
E2. Filtered aliquots had been passed through a 2.7 µm glass fiber filter to remove suspended 
organic content. These two samples were diluted 10-fold to ensure that they would not exceed 
limits of quantification. Concentrations were assessed at 10.376 and 14.437 ng/L respectively by 
GraphPad Prism, closely matching the values produced at the time using Abraxis proprietary 
software (10.509, 14.289). More importantly, this suggests that a significant portion of E2 is 
associated with suspended solids. The degree of variance between the above results for C4 
samples and those later produced during a whole-series analysis (Table 4) is likely attributable 
to the heterogeneity of sample aliquots, a complicating factor that is compounded by the 
dilution factors required given the matrix. 
 B and C-series samples were analyzed using gas chromatographic methods with gas 
chromatography-electron capture detector (GC-ECD) for triclosan, and with Abraxis kits for E2 
and triclosan. Triclosan standards were run separately to identify retention time for the 
compound, then peaks at that retention time in samples were integrated and their peak areas 
recorded. Concentrations are presented as Tables 4 to 6. Outliers are shaded, and are 
considered estimated values. 
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Table 4 – E2 results for B and C-series samples by Abraxis. 
Sample 
Conc. 
(ng/L) 
B1 US-1 325 
B2 US-1 160 
B3 US-1 179 
B4 US-1 115 
  
C1 US-1 160 
C1 US-1 unfiltered 189 
C2 US-1 105 
C3 US-1 140 
C4 US-1 76 
C4 US-1 unfiltered 391 
 
Table 5 - Triclosan results for B and C-series samples by Abraxis. 
Sample 
Conc. 
(µg/L) 
B1 US-1 0.5 
B2 US-
1 0.4 
B3 US-
1 1.0 
B4 US-
1 0.5 
  
C1 US-1 1.4 
C2 US-
1 1.0 
C3 US-
1 0.3 
C4 US-
1 0.5 
 
 
B-series estradiol and triclosan concentrations show a steady decrease from source 
water throughout treatment, with the exception of triclosan in anaerobic samples which show a 
slight upward trend. In triclosan data for C-series samples, the uptick occurs slightly later in the 
aerobic stage (C4). Unfiltered samples yielded higher concentration results than filtered as 
expected. 
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Table 6 - Triclosan results for B and C-series samples by GC-ECD. 
Sample Peak area 
B1 US-1 18412 
B2 US-
1 13063 
B3 US-
1 7849 
B4 US-
1 2322 
  
C1 US-1 32870 
C2 US-
1 25587 
C3 US-
1 22926 
C4 US-
1 14343 
 
 Chromatographic results could not be converted to concentrations because known 
addition results did not produce an expression relating instrumental response to concentration. 
This data is contained in Appendix F. The data in Tables 4 through 6 are visually presented in 
Figures 28-30.  
 
Figure 28 – E2 results from Abraxis kits for B and C-series samples. 
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Figure 29 - Triclosan results from Abraxis kits for B and C-series samples. 
 
Figure 30 - Triclosan results from GC-EDC for B and C-series samples. 
 
3.1.4 Discussion: SPE, GC-ECD and A, B and C-series samples 
These sample series were meant to be used to compare Abraxis and GC-MS results, in 
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quantification was not possible due to the issues with cartridge fouling during SPE, this problem 
highlights an important point regarding the application of the two methods. GC-MS or LC-MS 
are the prevailing approaches to quantifying environmental occurrence of micropollutants, yet 
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phase compounds not associated with anionic humic material (Stanford and Weinberg 2007). 
While extraction efficiency can be assessed using isotope dilution, introducing identifiable (for 
example, deuterated) standards to the sample prior to sample cleanup, spiked analytes may not 
behave identically to the corresponding compound which has been established in the matrix for 
longer, has undergone changes in environment in the presence of organic matter and other 
wastewater constituents, and is more likely to have interacted chemically with co-contaminants. 
To the degree that this is the case, standard addition even with more sophisticated elements 
such as isotope dilution may not accurately define extraction efficiencies which determine 
correction factors and ultimately an accurate result. 
 Practically, it is possible to further adapt the SPE procedure developed by Stanford and 
Weinberg (2007) to successfully extract analytes from high DOM septic samples. Because 
concentrations of micropollutants tend to be high relative to surface and groundwater samples, 
smaller sample volumes can be extracted without creating detection limit problems. This 
coupled with use of large capacity SAX cartridges could circumvent the complete blockage and 
breakthrough problems that precluded completion of the sample workup procedure as 
previously conducted. While these extracts may not reflect the true total concentration of 
compounds in the wastewater matrix where they are distributed among the particulate, 
dissolved organic and aqueous phases, they would not present a threat to the instrumental 
detector during chromatographic analysis and if sufficiently accurate means of determining 
extraction efficiency were found, could provide a more accurate and precise determination of 
compounds than the ELISA technique. 
 A-series samples were not analyzed because of breakthrough to the Strata X cartridge 
and subsequent contamination of extracts (Figure 16). Extraction of B and C-series samples 
was performed by using multiple SAX cartridges per sample, exchanging the cartridge inline 
with the Strata X for a fresh conditioned cartridge as breakthrough became imminent. While 
52 
 
this was sufficient to protect the final extract from excessive contamination, it may have 
contributed to a highly variable recovery of standard addition. Calibration points were not 
linear; addition of standards did not result in a proportional increase in peak area during GC-
ECD analysis. This points to irregular distribution of standard compounds throughout the 
sample.  
 Spikes were made prior to filtration in order to subject standard addition to the same 
extraction efficiency as corresponding environmentally-derived compounds and therefore 
accurately assess concentration in the source. These samples were then filtered, and drawn 
through extraction cartridges. Clogging of SAX cartridges was rapid, meaning that several 
cartridges were expended to flow 100-150 mL of sample for each sample. To extract the full 500 
mL sample volume would have required the expenditure of too many cartridges, and would have 
taken a prohibitively long time. Therefore, the extraction was discontinued and the remainder of 
the sample volume was measured. The analytical response was corrected based on the volume 
extracted to make results for different samples comparable.  
 This procedure clearly introduced substantial error at some point: one likely 
explanation is that perhaps the spiked compounds, despite vortexing and mixing during 
filtration, were not evenly distributed throughout the sample and so during extraction more or 
less of the spiked compound happened to be drawn and extracted from one sample to another, 
resulting in random over- or under-expression of the true overall post-spike concentration. 
Another possibility is that the practice of exchanging spent SAX cartridges for fresh ones during 
extraction results in variable extraction efficiency. Perhaps SAX cartridges nearing their sorptive 
capacity contain a bulk of organic matter that is liable to retain target compounds as they are 
drawn through, by presenting an organic phase that they are preferentially incorporated into on 
the basis of polarity. These results indicated that while extracts had been produced that were 
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sufficiently free of background noise and contamination for analysis, this technique was still not 
leading to accurate quantification of target compounds in samples. 
 In addition to making issues with SPE of wastewater with elevated organic content 
abundantly clear, the first four column study iterations also provided the first opportunity to 
apply the Abraxis kits for analysis of micropollutants. Aside from solving the logistical issues 
that were confounding progress, this method is an interesting one in its own right for its 
simplicity, rapidity and sensitivity. As discussed previously, the ELISA technique has found 
widespread use in medical applications in a screening capacity, where producing results is 
facilitated through its use to the point that they can be liberally produced, then follow-up is 
executed using more accurate and precise methodology, that is also more time consuming and 
expensive, as needed. Abraxis is manufacturing this sort of product for new applications in the 
agricultural, food quality, and environmental fields where new technology could lead to new 
regimens of testing and regulation. The application of Abraxis materials to wastewater has been 
investigated previously (Shelver et al. 2007, Farre et al. 2007, Ricart et al. 2010), but a 
substantial body of literature has not yet developed. Results from Abraxis analysis of wastewater 
samples are discussed below, followed by method validation and quality control initiatives. 
Implications of this work for use of the ELISA technique in this field are based on these findings 
and observations made throughout the application of this technology. 
3.1.5 Analysis of D-series samples 
D-series samples were analyzed for nitrogen species over a period of two weeks to test 
the persistence of the inhibitory effect of allylthiourea on transformation of nitrogen (Tables 
C1-3). Ammonia concentrations in D1.1 through D1.4 samples ranged from 46 to 108 mg/L. 
This variation is produced by actual change in the water sample concentrations, due to 
heterogeneity and change over time taking place in the reservoir and periodic replenishment 
with fresh wastewater. Reagents were well within their expiration date and the procedure was 
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conducted as specified in Hach instructions. However, as is apparent from the differences in 
duplicate values seen in Table C1, accuracy of this data was questionable, likely in part due to 
the sensitivity mismatch with the concentrations in water samples, requiring a 1:200 dilution. 
This technique was not employed for later sample series as the data quality was not worth the 
time investment required. It is recommended that if nitrogen transformation is to be quantified 
in the future, another method should be applied.  
Ammonia concentrations approaching 100 mg/L as observed do not qualify this as a 
high ammonia strength wastewater as the term is used to describe industrial or otherwise 
concentrated effluents, but these results indicate that source water is significantly less dilute 
than municipal wastewater (Ruiz et al. 2003).  
 Conclusions published in the literature have indicated that allylthiourea has a 
“permanent” effect (Ginestet et al 1998). It is inevitable that at some point nitrification would 
resume if unspiked wastewater were flowing through the column system. However, the time 
period required may be long enough that it is effectively permanent, which would require that 
the column system be repacked to reset the microbial activity therein for successive iterations of 
an experiment. While this is not optimal, as physical porosity and permeability characteristics 
would change somewhat and the microbial consortium established in the column is likely to be 
different upon being reestablished using different source water, it may be necessary.  
 This consideration raises the question of what equilibration time is required to 
establish a biofilm on column media. For the D-series experiment described above, a two-week 
acclimatization period was provided prior to a five day contact period after which samples were 
collected, but this was chosen more because it was the maximum practicable while completing 
the necessary iterations within the time span available than because it was determined to be 
sufficient through observation. Ideally the column system would be in constant operation for a 
long time period prior to taking samples. A survey of onsite biofiltration-based wastewater 
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treatment technologies indicates that startup times are on the scale of weeks to months; 
variables such as temperature, loading rate, substrate and flow pattern are certain to influence 
the rate of biological accumulation. The concept of a final or equilibrium biomass state is 
something of a fallacy, as wastewater and wastewater treatment is in a constant state of flux. A 
treatment system is constantly responding to changes in user variables, season, and interaction 
of finite and sustainable capacities for wastewater constituent sequestration (exhaustion of 
sorptive capacity can occur as microbially-catalyzed transformation continues). This 
notwithstanding, time pressure permitting it is ideal to assess system performance in terms of 
some fundamental parameters such as total suspended solids (TSS), TOC, ammonia, turbidity, 
BOD, perhaps indicator bacteria such as fecal coliform and e. coli. Determination of when 
reductions in these have reached their maximum rate would help to avoid comparing 
performance of a partially established biomass with that of a more fully developed microbial 
ecosystem and mistaking more efficient removal for an outcome of experimental variables.  
 
3.2 E-series column study and Z-series batch studies 
 3.2.1 Series overview 
 The E-series column study and Z-series batch studies were conducted to investigate 
baseline rates of removal of estradiol, caffeine and triclosan. Spikes contributed 1 µg/L to 
concentrations of estradiol, caffeine, estrone and ibuprofen above the background concentration 
in order to elevate their initial concentrations so as to more easily measure levels in treated 
samples. E-series samples were originally to be analyzed by GC-MS, in which case estrone and 
ibuprofen could have been quantified and used as additional experimental indicators. 
Background concentrations of caffeine had not been previously determined but Abraxis analysis 
showed levels ranging from 0.8 to 56.6 µg/L meaning that the spike level for caffeine 
contributed a negligible amount to the total. 
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 The column system had been completely emptied, washed, repacked and reestablished 
with flowing unspiked source water on 5.25.11. This source water was withdrawn from CCCC on 
5.24.11, part of a 35L volume stored in the 20° C constant temperature room for short term use. 
The column system was operated at roughly 2.5 L/day until 6.1.11 in order to more quickly 
distribute microorganisms throughout the system, ensure availability of nutrients, and rapidly 
acclimatize the columns and establish a biofilm. On 6.1.11 Reservoir 1 was refilled with source 
water containing spikes described above, and E-series samples were collected 6.6.11. 
 The same source water was used to establish Z-series batch studies, which were 
initiated on 5.25.11. Unspiked wastewater was added to 6 batches which were then acclimatized 
for one week. On 6.1.11 liquid was discarded and all were refilled, three with unspiked source 
water and three with source water containing 1 µg/L spikes of estradiol, caffeine, ibuprofen and 
estrone. One of each set was an autoclaved batch; water added to that flask was separately 
autoclaved as well. These six batches were maintained on a shaker for a five day contact time at 
20° C; autoclaved and active aliquots of source water were also set aside off the shaker to assess 
baseline decay and microbial activity. On 6.6.11, the batches designated Z1-8 were sampled. In 
Table 7 below, sample labels are identified with the treatments applied to batches; spiked 
indicating that analyte concentrations were elevated in the source water, active signifying that 
the batch was not autoclaved and is assumed to have been biologically active, autoclaved 
indicating that microorganisms had been thermally inactivated in liquid and media separately, 
and no media indicating that those batches were in fact aliquots of source water kept off the 
shaker as controls, without any contact with the substrate used in the column system and in 
other batches.  
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Table 7 - Identification of sample labels with batch treatments. 
 
 
 
 
 
  
3.2.2 Dissolved oxygen 
 DO during the acclimatization and contact time for these studies was measured in the 
column system was analyzed on 6.2.11, with results presented in Table 8. Batch study DO was 
measured on 5.30.11, adjustments were made and measurements were taken again on 6.1.11. 
Results are presented in Table 9.  
 
Table 8 – DO (mg/L) in column system samples. 
Date Reservoir 1 Hypoxic Anaerobic Aerobic 
6.2.11 0.19 1.52 0.90 4.47 
 
 
Table 9 – DO (mg/L) in batch study samples. 
Date Spiked, 
active 
Unspiked, 
autoclaved 
Unspiked, 
active 
Spiked, 
active 
Unspiked, 
active 
Spiked, 
autoclaved 
5.30.11 0.73 0.07 4.16 0.11 0.00 3.62 
6.1.11 4.55 4.50 4.30 4.63 4.85 4.45 
 
The batch studies serve to separate the processes responsible for transformation of 
analytes during aerobic treatment, which requires that DO be maintained at a similar level as in 
Key     
Z1=  spiked, active   
Z2=  unspiked, autoclaved  
Z3=  unspiked, active   
Z4=  spiked, active   
Z5=  unspiked, active   
Z6=  
spiked, 
autoclaved   
Z7=  unspiked, active, no media  
Z8 =  unspiked, autoclaved, no media  
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the aerobic column. Originally it was assumed that for the batches modeling aerobic treatment 
to remain aerobic, it would be necessary to manually add oxygen. A frit was used to facilitate 
oxygen transfer from pressurized air, bubbled through the batch study substrate. However, it 
was found that uncapped batches maintained on a shaker were able to remain fully oxygenated 
(above 4 mg/L) without any further intervention. Continuous free exchange with atmospheric 
gas alters the general conservation of materials that batch studies observe, but as none of the 
analytes under consideration are volatile, this does not significantly impact the experimental 
objective of comparing treatments in terms of micropollutant reduction. 
 3.2.3 Organic carbon in columns 
 Non-purgeable organic carbon (NPOC) was quantified in 1:100 and 1:1000 dilutions of 
E-series samples without filtration and is reported as TOC. Results are presented as Table 10. 
After dilution correction, 1:1000 dilutions yielded higher concentrations. These measurements 
are presented graphically as Figure 31. The relative percent difference for the two results based 
on different dilution levels was calculated and is included below as Table 11.  
Table 10 - TOC (mg/L) in E-series samples. 
Sample TOC TOC dilution corrected Sample TOC 
TOC dilution 
corrected 
E1 1:100 2.3 230   E1 1:1000 0.34 340 
E2 1:100 1.9 19   E2 1:1000 0.25 250 
E3 1:100 1.6 160   E3 1:1000 0.23 230 
E4 1:100 1.8 180   E4 1:1000 0.27 270 
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Figure 31 - TOC results for two dilutions of E-series samples. 
 
Table 11 - interpretation of E-series TOC measurements. 
 
Relative percent 
difference 
E1 38 
E2 30 
E3 39 
E4 38 
 
 
 3.2.4 TN in columns 
Total nitrogen results are presented below as Tables 12 and 13, and Figure 32.  
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Table 12 - TN results for two dilutions of E-series samples (mg/l). 
 TN TN dilution corrected  TN 
TN dilution 
corrected 
E1 1:100 0.73 73   
E1 
1:1000 0.048 48 
E2 1:100 0.82 82   
E2 
1:1000 0.055 55 
E3 1:100 0.74 74   
E3 
1:1000 0.076 76 
E4 1:100 0.93 93   
E4 
1:1000 0.12 120 
 
 
 
Figure 32 – TN results for two dilutions of E-series samples. 
 
Table 13 - Interpretation of E-series TN measurements. 
 
Relative percent 
difference 
E1 41 
E2 39 
E3 2 
E4 26 
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 3.2.5 Bioassay results 
 Analysis of E-series column system samples and Z-series batch studies using Abraxis 
kits is presented in Table 14. Color coding identifies the day individual samples were tested, as 
analysis of these samples was conducted in two sessions a day apart. On the first day dilution 
factors were tested prior to consuming a substantial quantity of Abraxis materials, then having 
determined that dilution was suitable, the remainder of samples were assessed the next day. 
Table 14 – Analysis of E-series column system and Z-series batch study samples using Abraxis kits. 
Estradiol 
(ng/L) 
Caffeine 
(µg/L) 
Triclosan 
(µg/L) 
E1 252 56.6 2.2 
E2 222 25.3 1.2 
E3 114 27.7 1.0 
E4 69 21.8 0.6 
Z1     0.6 
Z2 197 36.5 0.7 
Z3 23 0.8 0.3 
Z4 31     
Z5 16 2.0 0.4 
Z6 79 84.0 0.6 
Z7 52 4.6 0.5 
Z8 109 52.2 1.0 
    
  <-6.6.11   <-6.7.11 
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 As discussed in the previous chapter, during the 
procurement of this data the concept of using a reduced 
number of calibration points for Abraxis tests for a given kit 
was explored. Interpolation of the estradiol and caffeine 
results from 6.7.11 are based on the calibration curve from 
6.6.11, corrected based on two standard points. The triclosan 
results from both days were interpolated based on calibration 
curves produced alongside sample results, simultaneously. 
 Dilution of samples was performed using the factors 
listed in Table 15. Correction for dilution has already been 
applied to the values in Table 14. The corrected results are 
visually presented in Figure 33 for the column and Figure 34 for the batch studies. 
Concentrations of all analytes decreased throughout progressive treatment in column system 
samples. 
Table 15 - Dilution factors for E-series column 
system and Z-series batch study samples. 
Sample Dilution factor 
E1 20 
E2 20 
E3 10 
E4 10 
Z1 10 
Z2 10 
Z3 5 
Z4 10 
Z5 5 
Z6 20 
Z7 5 
Z8 10 
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Figure 33 - E-series sample concentrations. 
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Figure 34 - Z-series triclosan concentrations. 
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 Interpretation of this data is provided in Tables 16-20 below. Sample identification 
includes a description, in addition to labels. Column study analyte concentration values are 
converted to percentage reduction relative to the source water drawn from Reservoir 1. 
Additionally, values are expressed as percentages of the preceding sample, in order to facilitate 
determination of which stages produced the most dramatic reduction irrespective of initial 
absolute concentration. Increases in concentration are highlighted; yellow highlighting was used 
for column system samples and green for batches as the explanation for increases differs 
between the two. 
Table 16 - Interpretation of estradiol results for E-series samples. 
 
 % of source % removal % of prior 
Reservoir 1 (E1) 100 0  
Post-hypoxic (E2) 88 12 88 
Post-hypoxic, anoxic (E3) 45 55 51 
Post-hypoxic, anoxic, aerobic (E4) 27 73 61 
 
Table 17 - Interpretation of caffeine results for E-series samples. 
 
 % of source % removal % of prior 
Reservoir 1 (E1) 100 0  
Post-hypoxic (E2) 45 55 45 
Post-hypoxic, anoxic (E3) 49 51 110 
Post-hypoxic, anoxic, aerobic (E4) 38 62 79 
 
Table 18 - Interpretation of triclosan results for E-series samples. 
 
 % of source % removal % of prior 
Reservoir 1 (E1) 100 0  
Post-hypoxic (E2) 52 48 52 
Post-hypoxic, anoxic (E3) 44 56 85 
Post-hypoxic, anoxic, aerobic 
(E4) 27 73 60 
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 Batch studies are less clearly linear in progression, so interpretation normalizes each to 
a percentage of the source water (represented by Reservoir 1 from E-series column system 
samples). These are converted to removal values as before. Descriptions from the key above are 
substituted for sample names to make it easier to associate values with experimental variables. 
The list of removal values linked with batch descriptions is then sorted from low to high removal 
rates, and the hypothesized factors leading to reduction of analytes implicit in batch treatments 
are listed on the right. These will be discussed in greater detail in the next chapter. Negative 
removal values are highlighted. Blank fields correspond to outlier results that were not 
interpolated by GraphPad. 
Table 19 - Interpretation of estradiol results for Z-series batch studies. 
 
 % of source % removal 
Reservoir 1 (E1) 100 0 
spiked, active (Z1)  
unspiked, autoclaved (Z2) 78 22 
unspiked, active (Z3) 9 91 
spiked, active (Z4) 12 88 
unspiked, active (Z5) 6 94 
spiked, autoclaved (Z6) 31 69 
unspiked, active, no media (Z7) 21 79 
unspiked, autoclaved, no media (Z8) 43 57 
 
Sorted by removal percentage, lowest to highest 
Sample 
% 
removal 
Hypothesized factors 
responsible  
unspiked, autoclaved (Z2) 22 oxygen availability, media 
unspiked, autoclaved, no media 
(Z8) 57 oxygen availability, settling 
spiked, autoclaved (Z6) 69 oxygen availability, media 
unspiked, active, no media (Z7) 79 oxygen availability, activity 
spiked, active (Z4) 88 
oxygen availability, media, 
activity 
unspiked, active (Z3) 91 
oxygen availability, media, 
activity 
unspiked, active (Z5) 94 
oxygen availability, media, 
activity 
spiked, active (Z1)  
oxygen availability, media, 
activity 
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Table 20 - Interpretation of caffeine results for Z-series batch studies. 
 % of source % removal 
Reservoir 1 (E1) 100 0 
spiked, active (Z1)   
unspiked, autoclaved (Z2) 65 35 
unspiked, active (Z3) 1 99 
spiked, active (Z4)   
unspiked, active (Z5) 4 96 
spiked, autoclaved (Z6) 148 -48 
unspiked, active, no media (Z7) 8 92 
unspiked, autoclaved, no media (Z8) 92 8 
 
 
 
Sorted by removal percentage, lowest to highest 
Sample % removal Hypothesized factors responsible  
spiked, autoclaved (Z6) -48 oxygen availability, media 
unspiked, autoclaved, no 
media (Z8) 
8 oxygen availability, media, settling 
unspiked, autoclaved (Z2) 35 oxygen availability, 
media 
unspiked, active, no media 
(Z7) 
92 oxygen availability, 
settling, activity 
unspiked, active (Z5) 96 oxygen availability, 
media, activity 
unspiked, active (Z3) 99 oxygen availability, 
media, activity 
spiked, active (Z1)   
spiked, active (Z4)   
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Table 21 - Interpretation of triclosan results for Z-series batch studies. 
 
 % of source % removal 
Reservoir 1 (E1) 100 0 
spiked, active (Z1) 28 72 
unspiked, autoclaved (Z2) 32 68 
unspiked, active (Z3) 14 86 
spiked, active (Z4)   
unspiked, active (Z5) 17 83 
spiked, autoclaved (Z6) 28 72 
unspiked, active, no media (Z7) 24 76 
unspiked, autoclaved, no media (Z8) 43 57 
 
 
Sorted by removal percentage, lowest to highest 
Sample 
% 
removal 
Hypothesized factors 
responsible  
unspiked, autoclaved, no media 
(Z8) 57 oxygen availability, settling 
unspiked, autoclaved (Z2) 68 oxygen availability, media 
spiked, active (Z1) 72 
oxygen availability, media, 
activity 
spiked, autoclaved (Z6) 72 oxygen availability, media 
unspiked, active, no media (Z7) 76 oxygen availability, activity 
unspiked, active (Z5) 83 
oxygen availability, media, 
activity 
unspiked, active (Z3) 86 
oxygen availability, media, 
activity 
spiked, active (Z4)  
 
 
3.2.6 Discussion: E and Z-series samples 
 E-series column studies and Z-series batches were used to investigate baseline 
conditions. Spikes were made of all analytes to elevate them to measurable concentrations, an 
undertaking deemed unnecessary once data had been produced that revealed the actual initial 
concentrations of micropollutants in the source water (Samples B1 and C1 in Tables 4 and 5). 
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In columns, concentrations of target compounds followed an overall trend of declining steadily 
throughout the successive stages of treatment.  
 The reemergence of triclosan following anaerobic treatment would at first appear to be 
happenstance but for the reoccurrence of this trend in later column studies (Figure 38, 
Figures 47 and 48). One potential explanation is that after a five-day contact time the “plume” 
of spiked compounds has broken through the anaerobic column but has not carried fully into the 
aerobic column’s outflow, which is conceivable in terms of flow rate but would not explain an 
upward trend from the hypoxic to anaerobic column. Another possibility is that the anaerobic 
matrix somehow elevates the analytical response, such that there are more positive matrix 
effects with anaerobic samples than others. Yet another possibility is that the anaerobic aliquots 
are capable of less reduction during hold times between sample collection and analysis than 
others, given that each has greater access to oxygen during hold times than during normal 
operation. Hold times for column system samples were on the order of hours between sampling 
and analysis. 
 The upward trend could also be a product of analytical procedure, specifically dilution. 
Because samples from different stages of treatment are diluted to varying extents, they do not 
necessarily lie within the range of detection in the order relative to one another that you would 
expect from their final corrected concentrations. If the ELISA technique overestimates more in 
one section of the range of detection than another, the dilution factors employed could 
consistently put one stage’s samples in that section, leading to systematic manifestation of a 
trend in the relative concentrations that are produced. 
 Hypothesizing about causes is somewhat premature at this point. If this trend is 
observed on an ongoing basis then it may be considered a valid observation to investigate, but at 
this point it cannot be confirmed as more than a coincidence. Repetition of experiments is 
necessary to validate all findings here. This data in general could have been interpreted to a 
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greater extent; ultimately the marginal change as treatment factors are applied in batches, and 
column study iterations should be convertible to a quantitative breakdown of which treatment 
factors are responsible for what percent of total removal on a target compound-specific basis. 
This would require enough duplicate batches to ameliorate variance from batch to batch 
statistically, and to quantify uncertainty in a more meaningful way than relative percent 
difference. Scale-up to this extent was not possible up until this point, and was probably not 
warranted given that this was exploratory work following the creation of a new experimental 
apparatus and procedure, and the application of a new analytical method. Now that the concept 
has been demonstrated and experience working with these design elements gained, the project 
is ready for scale-up, and production of defensible results on the fundamental nature of 
micropollutant dynamics in wastewater treatment systems. 
Total nitrogen measurements should represent the sum of ammonia, nitrite and nitrate 
analyzed using Hach kits (Appendix D). An increase in the total nitrogen across the E-series 
column system samples (Figure 32) are not easily explained in terms of nitrogen production 
throughout treatment. Probable reasons for the measurement include inaccuracy in 
quantification, particularly due to heterogeneity of sample from which an aliquot is taken and 
diluted and the potential for matrix effects which affect one nitrogen species differently from 
another, and also irregularities in the dynamics of the column system at the time when it was 
sampled.  It is possible that refill events cause flux through the column of particularly 
concentrated water, and also on a reservoir by reservoir basis as liquid levels drop it is possible 
that settled more concentrated strata are taken up through the outlet tube and momentary 
spikes in nitrogen species and total nitrogen could occur. This explanation is unlikely to apply to 
the E-series measurements because a consistently increasing trend was observed through all 
four system samples.  
71 
 
 In Z-series batch samples, incremental factors for treatment generally correlated with 
higher removal rates indicating that the concept of the batch studies is not obscured by co-
variables (Tables 19-21). Details about the relationship between the various batches are 
somewhat problematic, such as the equal degrees of removal associated with autoclaved and 
active spiked batches for triclosan. However, overlap is expected for treatment combinations 
that are adjacent in the overall order of batches expected to produce the lowest removals to 
highest, and these seeming contradictions should be resolved by duplication and application of 
statistical analyses to determine the significance of correlation between treatment and removal. 
The general resolution in each marginal addition of a treatment factor in terms of removal is 
quite good. Caffeine results are entirely logically interrelated with no apparent contradictions to 
be explained. Estradiol results in general are more highly variable likely because of the lower 
concentrations and more sensitive analytical method. The spiked autoclaved sample (Z6) had a 
lower final concentration than the unspiked autoclaved sample (Z8, see Table 14) and spike 
levels were much less negligible for estradiol than for caffeine and triclosan. Spiked and 
unspiked active batches were not differentiated by removal rates. Perhaps in this case there was 
an issue causing the actual estradiol introduced to be less than intended, or perhaps the sorption 
to media in this batch study series happened to obscure the different initial concentrations. Even 
for this relatively difficult to explain data series, autoclaved aliquots all yielded lower rates of 
removal than active batches and the lack of media would appear to have resulted in significantly 
reduced removal rates relative to batches with media so as a proof of concept these results still 
represent a positive outcome. Reproduction of this experiment with enough duplicates to apply 
statistical analysis should allow ranking and quantitative proportions to be assigned each type of 
treatment taking place in batch studies, specific to each analyte. 
 Negative removals are not indications of erroneous results in these tables because 
removal has been normalized to Reservoir 1 in the column system and not the actual starting 
concentration of the source water that was introduced to the batches. A certain background rate 
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of decay is expected for all target compounds in wastewater, and so a reference point that had 
spent the same amount of time sitting, in the same conditions as treatment aliquots 
incorporates this loss to avoid attributing it to treatments. In addition to that rate of decay, there 
is anaerobic removal incorporated into Reservoir 1’s concentrations, which in some cases 
outstrips the removal of batches, most predictably the autoclaved batches. As is apparent in DO 
measurements (Table 23), Reservoir 1 was not always anaerobic in practice as oxygen entered 
the headspace during sampling events or refills and was difficult to expunge completely. While 
this was not undesirable for purposes of column study experiments, as oxygen introduced to 
Reservoir 1 caused the hypoxic column to be more oxygenated than the anaerobic column, as 
intended, it complicates the use of Reservoir 1 as a basis for normalization of batch study results. 
The real value of normalization is that it orders the batches relative to one another, and so the 
fact that the basis for comparison does not represent a true zero treatment source water does 
not invalidate the experiment. 
3.3 Discussion: Analytes as experimental controls 
 The E-series samples were the first to be analyzed after kits were received from Abraxis 
that allowed for the analysis of caffeine, in addition to estradiol and triclosan. This is important 
because the target compounds serve as experimental controls in a way, as does the incremental 
treatment of batches, to explore the mechanisms of treatment of micropollutants within the 
column system. 
 As covered in the introduction, different types of treatment are hypothesized to be 
responsible for the elimination of each analyte during treatment in the literature. Caffeine is 
demonstrated to be efficiently removed by microbial treatment (Buerge et al. 2003), but no 
connection has been made between removal of caffeine and the nitrifying subset of bacteria. 
Estradiol, on the other hand, has been found to be metabolized by nitrifying bacteria in a variety 
of matrices (Clouzot et al. 2008). Removal of triclosan is also thought to be related to the activity 
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of nitrifying bacteria, but it has been found to have an inhibitory effect on isolated cultures of 
AOB and may suppress activity of nitrifiers in a wastewater treatment context (Roh et al. 2009). 
Therefore, removal of caffeine is an indication of microbial activity, estradiol reductions are 
indicative of nitrification activity, and triclosan is both an input to and a metabolite of the 
nitrifying subset of microorganisms.  
 Additional analytes to be used as controls were identified but had to be cut because 
analytical methods were not available to quantify baseline concentrations and monitor their fate 
throughout the column system, or following contact times in batches. These included ibuprofen, 
estrone and nonylphenol. Ibuprofen is similar to caffeine in that it is microbially mineralized 
and that process is not linked to nitrification, though it is more recalcitrant during treatment 
and some researchers have found it to be physically removed to a significant degree (Buser et al. 
1999). This is probably connected to its low solubility, which is the most important 
differentiating factor between it and caffeine for the purposes of this study. The affinity for 
sorption would be another marginal treatment mechanism that would be defined by the 
difference between autoclaved batches without media and autoclaved batches with media. The 
microbial subset that is responsible for the removal of these compounds has not been defined to 
date, so screening them to see if their removal responds to nitrification inhibition would be a 
reasonable preliminary test. 
 Estrone would be useful primarily for distinguishing between physically catalyzed and 
microbial removal. Estradiol can be transformed into estrone through interaction with physical 
media or by biological metabolism, whereas estrone is mineralized by microbial action alone 
(Das et al. 2004). This can result in the apparent reappearance of estrone in later stages of 
treatment due to the decay of estradiol, as observed in the results by Stanford and Weinberg 
(2010) as shown in Figure 35. 
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Figure 35 - Steroid hormone and nonylphenol concentrations in successive stages of onsite 
treatment. E1 = estrone. (Stanford and Weinberg 2010) 
 
 Nonylphenol behaves in a manner similar to triclosan in that it has been hypothesized 
to have an inhibitory effect on nitrifying bacteria (Stasinakis et al. 2008). Both nonylphenol and 
triclosan are of interest for current policy reasons as well. Nonylphenol has been banned in the 
European Union (Renner 1997) for its endocrine disruption potential in the environment, but in 
the U.S. it is a degradation product of commonly used nonionic surfactants in household 
products. Research that sheds light on consequences for impacted organisms, and the effects 
nonylphenol potentially has on wastewater treatment and removal of other wastewater 
constituents will help policy makers weigh the economic cost of banning the chemical against 
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the improvement in environmental quality more effectively. Nonylphenol has another 
mechanism of influence over triclosan; in its primary commercial application as a component of 
alkylphenol ethyloxylate (APE), it can affect the transport of co-contaminants through soil as a 
surfactant (Stanford et al. 2010). It would be an interesting chemical to study at spiked 
concentrations while monitoring the levels of other micropollutants throughout the column 
system. This could have been done despite the lack of a means to quantify nonylphenol, but the 
absence of baseline data with which to gauge how high the starting concentration was and how it 
distributed throughout the column system would have constituted a major gap in the supporting 
information for the experiment, to the point that it was judged to be a dealbreaker. Triclosan is 
under review by the Food and Drug Administration (FDA) for its potential to cause the 
generation of drug-resistant microbes (Doheney 2010). Its widespread use and persistence 
through wastewater treatment result in exposure of microbes to non-lethal dosages. This is the 
textbook scenario in which resistance is selected for and developed in a population, thereby 
leading to decreased effectiveness of the biocide, and the creation of more resilient biota. This 
principle has implications for wastewater treatment, in addition to public health. 
 One other general note regarding these experiments is that baseline concentrations of 
target compounds were substantial in 
source waters, even before any artificial 
elevation. Onsite treatment systems do 
not receive influent diluted by 
stormwater and non-sewage generating 
users, and so micropollutant 
concentrations can be especially high- 
another justification for conducting this study 
within an onsite treatment context. Therefore, when spiking chemicals into the wastewater used 
in batch and column studies, the increase is marginal and the comparison is not between zero 
Figure 36 - Generalized dose-response curve. 
http://www.graphpad.com/curvefit/introduction89.htm 
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and X treatment; rather, it is between X and X+Y treatment. If this point is put in the context of 
a dose response curve, the general shape of which is depicted in Figure 36, the treatments are 
not contrasting a dose of zero with a 50% dose, they are in a best case scenario between perhaps 
25% and 75%. It is possible that the baseline dose has already produced the maximum response 
and so no effect will be observed between treatment and control batches/ column study samples, 
due to the relation of effective doses utilized in the study to the dose-response range for that 
compound in a given matrix.  
3.4 F-series column study and Y-series batch studies 
 The F-series column study and Y-series batch studies were conducted to explore the 
differences in removal efficiency between treatment where nitrification is inhibited, and 
uninhibited controls. F-series samples were taken in two staggered sampling events, F1-4.1, and 
F1-4.2. The column system had been in continuous operation flowing unspiked source water 
since 6.14.11, before which it was exhausting the spiked source water used for the E-series 
experiment. On 7.7.11, F1-4.1 column samples were collected from an unspiked system. 
Reservoir 1 was immediately refilled with source water spiked with allylthiourea at 10 mM. After 
a 5 day contact time, inhibited column system samples were taken (F1-4.2) on 7.13.11. 
 Source water used to supply the column system and fill batch studies was withdrawn 
from CCCC on 6.13.11. Treatment of batches was analogous to that used for Z-series 
experiments. Unspiked wastewater was used to fill 6 batches on 6.22.11 which were acclimatized 
for two weeks. On 7.7.11, the supernatant liquid was decanted and discarded and all reaction 
vessels were refilled, three with unspiked source water and three with source water containing 
spikes of allylthiourea, again at 10 mM. One of each set was an autoclaved batch; water added to 
that flask was separately autoclaved as well. These six batches were maintained on a shaker for a 
five day contact time; autoclaved and active aliquots of source water were also set aside off the 
shaker to assess baseline decay and microbial activity. These batches were broken down and 
77 
 
sampled on 7.13.11 with sample designations Y1 to 8 as described in Table 22. The term 
nitrifying indicates a batch that was not spiked with allylthiourea and, therefore, was assumed to 
be conducive to nitrification by the relevant microbia. In inhibited active batches, biological 
activity was assumed to be present but the nitrifying subset is inactive. Autoclaved batches are 
without biological activity, nitrifying or otherwise. The label “no media” again refers to batches 
that were in fact aliquots of source water kept off the shaker as controls, without any contact 
with the substrate used in the column system and in other batches.  
Table 22 - Identification of sample labels with batch treatments. 
Key   
Y1= nitrifying, autoclaved 
Y2= nitrifying, active 
Y3= nitrifying, active 
Y4= inhibited, autoclaved 
Y5= inhibited, active 
Y6= inhibited, active 
Y7= nitrifying, autoclaved, no 
media 
Y8= nitifying, active, no media 
 
 3.4.1 Dissolved oxygen in columns and batches 
 DO during the acclimatization and contact time for these studies was measured in the 
column system on 7.6.11; results are presented below in Table 23. Batch study DO was 
measured on 7.5.11; results are presented in Table 24.  
Table 23 - DO in column system, 7.6.11 (mg/L). 
Date Reservoir 1 Hypoxic Anaerobic Aerobic 
7.6.11 1.71 0.78 0.12 1.28 
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Table 24 - DO in batch samples, 7.5.11 (mg/L). 
Date Y1 Y2 Y3 Y4 Y5 Y6 
7.5.11 4.37 4.58 4.45 4.83 4.19 4.38 
 
 3.4.2 Organic carbon in F and Y-series samples 
 TOC was measured in 1:100 dilutions of F and Y-series samples. Blank values are 
consequences of instrumental error, which caused the measurement to not be taken. Results are 
presented in Table 25. These measurements are presented graphically as Figure 37. A figure 
representing FX.1 samples was omitted because instrumental error removed too significant a 
portion of the data that would have been used to produce that graph. In these experimental 
series, the primary determinative factor controlling result was addition of allylthiourea, and so 
these results generally are not considered indicative of source water characteristics. 
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Table 25 - TOC in F and Y-series samples (mg/L as C). 
 TOC TOC dilution corrected 
F1.1   
F2.1   
F3.1 0.69 69 
F4.1 0.43 43 
   
F1.2 4.6 460 
F2.2 5.5 550 
F3.2 7.5 750 
F4.2 5.1 510 
   
Y1 0.75 75 
Y2 0.52 52 
Y3   
Y4 4.9 490 
Y5 4.5 450 
Y6 4.5 450 
Y7 0.97 97 
Y8 0.61 61 
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Figure 37 - TOC data from F and Y-series samples. 
 
 3.4.3 TN in columns and batch studies 
 TN was also measured in 1:100 dilutions of F and Y-series samples. Results are 
presented as Table 26 and plotted as Figures 38-39. A figure representing FX.1 samples was 
omitted because instrumental error removed too significant a portion of the data that would 
have been used to produce that graph. In these experimental series, as with TOC, the primary 
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determinative factor controlling TN result was addition of allylthiourea, and so these results 
generally are not considered indicative of source water characteristics. 
Table 26 - TN results for F and Y-series samples (mg/L). 
 TN TN dilution corrected 
F1.1   
F2.1   
F3.1 0.44 44. 
F4.1 0.070 7.0 
   
F1.2 2.7 270 
F2.2 3.1 310 
F3.2 4.2 420 
F4.2 3.0 300 
   
Y1 0.26 26 
Y2 0.35 35 
Y3   
Y4 2.8 280 
Y5 2.5 250 
Y6 2.6 260 
Y7 0.31 31 
Y8 0.40 40 
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Figure 38 - TN results for FX.2 samples. 
 
 
Figure 39 - TN results for Y-series samples. 
 
 3.4.4 Bioassay results 
 Results of analysis of F-series column system samples and Y-series batch studies for 
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discussed in section 3.8.2, a three-parameter curve was employed to fit marginal results, with a 
slight tradeoff in curve fit. 
Table 27 - F-series column system and Y-series batch study results from Abraxis analysis. 
 
Estradiol (ng/L) Triclosan 
(µg/L) 
Caffeine 
(µg/L) 
F1.1 196 2.0 5.2 
F2.1 33 2.5 1.3 
F3.1 48 22.8 1.8 
F4.1 33 1.6 0.9 
F1.2 84 2.5 1.1 
F2.2 27 3.9 1.0 
F3.2 104 2.1 0.8 
F4.2 224 2.6  
Y1 133 0.9 7.0 
Y2 45 0.5 0.5 
Y3 15 0.6 0.5 
Y4 113 1.1 5.2 
Y5 57 0.9 2.0 
Y6 17 1.3 1.1 
Y7 210 3.5 15.9 
Y8 113 1.2 1.0 
    
  <-- 4-param   <-- 3-param 
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 Dilution factors were adapted from earlier values, adjusted based on anticipated 
alterations in treatment, and encroachments on upper 
and lower bounds to the range in which absorbance 
values could be quantified during previous sample 
series. Table 28 lists dilution factors for F-series 
column study samples and Y-series batch studies. 
 Correction for dilution has already been applied 
to concentrations shown in Table 27. The corrected 
results are visually presented as Figures 40-41. Subset 
graphs clarify the trends for analytes where their trend 
was obscured in combined figures due to incompatible 
scales. In FX.1 samples, a slight increase in 
concentration was observed for all three analytes from 
F2 to F3 (i.e. between the effluents of the hypoxic and 
anaerobic columns), contrary to the overall downward 
trend. In FX.2 samples, estradiol increases from each stage to the next after F2.2. Caffeine is the 
only analyte showing a downward trending pattern throughout, while triclosan alternates 
between increasing and decreasing from one stage to another after an initial upswing from F1.2 
to F2.2. 
Table 28 - Dilution factors for F-series column 
and Y-series batch study samples for Abraxis 
analysis. 
Sample Dilution factor 
F1.1 20 
F2.1 20 
F3.1 10 
F4.1 10 
F1.2 20 
F2.2 20 
F3.2 20 
F4.2 20 
Y1 10 
Y2 5 
Y3 5 
Y4 10 
Y5 10 
Y6 10 
Y7 20 
Y8 10 
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Figure 40 – FX.1 sample concentrations. 
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Figure 41 - FX.2 sample concentrations. 
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already in the system, and had not been spiked or treated. However, since it had been collected 
(6.13.11) the portion not being used had been stored without being disturbed at all, and visually 
appeared to have clarified to a substantial degree. When this water was used to refill the system, 
after flowing for five days the preceding less settled portion appeared to have been displaced 
from the first half of the system but not entirely from the latter two reservoirs.  
 When water flows through the system, there is a gradual transition in each reservoir 
from the old to the new water being added, due to the design element of reservoirs between each 
stage. Partially treated water in the reservoir between the hypoxic and anaerobic columns is not 
displaced into the next column. Instead it is gradually diluted out. Therefore, if a change is made 
to the water being introduced to the top of the hypoxic column from reservoir 1, it will take 
considerably more time for that water to saturate the system through the aerobic stage than 
would be projected given flow rate and column volume. 
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Figure 42 – Batch (Y-series) sample concentrations. 
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 Interpretation of this data is provided in Tables 29-34. Increases in concentration are 
highlighted; yellow highlighting was used for column system samples, green for batches as the 
explanation for increases differs between the two. In batches, the qualifier nitrifying and other 
(n+o) activity signifies that the biological activity included the nitrifying subset, whereas other 
(o) activity describes an active batch where nitrification was inhibited, and only microbes other 
than nitrifiers were active.  
 An additional step is taken where the difference between treatment and control 
samples that correspond is quantified for batch studies. As duplicate inhibited active batches 
and duplicate nitrifying batches were conducted, the duplicates were averaged for comparison, 
with the disparity between duplicates quantified in terms of relative percent difference (Tables 
32 to 34). 
Table 29 - interpretation of estradiol results for F-series samples. 
 
 % of source 
% 
removal % of prior 
F1.1 100 0  
F2.1 17 83 17 
F3.1 24 76 143 
F4.1 17 83 69 
    
F1.2 100 0  
F2.2 32 68 32 
F3.2 124 -24 383 
F4.2 267 -167 216 
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Table 30 - interpretation of caffeine results for F-series samples. 
 
 % of source 
% 
removal 
% of 
prior 
F1.1 100 0  
F2.1 25 75 25 
F3.1 35 65 140 
F4.1 17 83 48 
    
F1.2 100 0  
F2.2 90 10 89 
F3.2 76 24 84 
F4.2    
 
Table 31- interpretation of triclosan results for F-series samples. 
 
 % of source % removal 
% of 
prior 
F1.1 100 0  
F2.1 125 -25 125 
F3.1 1155 -1055 922 
F4.1 81 19 7 
    
F1.2 100 0  
F2.2 154 -54 154 
F3.2 82 18 53 
F4.2 102 -2 124 
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Table 32 - interpretation of estradiol results for Y-series samples. 
 
 % of source % removal 
Reservoir 1 (F1.1) 100 0 
nitrifying, autoclaved (Y1) 68 32 
nitrifying, active (Y2) 23 77 
nitrifying, active (Y3) 8 92 
inhibited, autoclaved (Y4) 57 43 
inhibited, active (Y5) 29 71 
inhibited, active (Y6) 9 91 
nitrifying, autoclaved, no media 
(Y7) 107 -7 
nitifying, active, no media (Y8) 58 42 
 
Sorted by removal, least to most 
nitrifying, autoclaved, no media 
(Y7) -7 oxygen availability, settling 
nitrifying, autoclaved (Y1) 32 oxygen availability, media 
nitifying, active, no media () 42 oxygen availability, n+o activity 
inhibited, autoclaved 43 oxygen availability, media 
inhibited, active 71 oxygen availability, media, o activity 
nitrifying, active 77 
oxygen availability, media, n+o 
activity 
inhibited, active 91 oxygen availability, media, o activity 
nitrifying, active 92 
oxygen availability, media, n+o 
activity 
 
Overall difference, nitrifying vs. inhibited 
avg. of duplicates % removal rel. % diff 
inhibited, active 81 25 
nitrifying, active 85 18 
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Table 33 - interpretation of caffeine results for Y-series samples. 
 
 % of source % removal 
Reservoir 1 (F1.1) 100 0 
nitrifying, autoclaved (Y1) 134 -34 
nitrifying, active (Y2) 10 90 
nitrifying, active (Y3) 9 91 
inhibited, autoclaved (Y4) 99 1 
inhibited, active (Y5) 39 61 
inhibited, active (Y6) 21 79 
nitrifying, autoclaved, no media (Y7) 306 -206 
nitifying, active, no media (Y8) 20 80 
 
Sorted by removal, least to most 
nitrifying, autoclaved, no media 
(Y7) -206 oxygen availability, settling 
nitrifying, autoclaved (Y1) -34 oxygen availability, media 
inhibited, autoclaved (Y4) 1 oxygen availability, media 
inhibited, active (Y5) 61 oxygen availability, media, o activity 
inhibited, active (Y6) 79 oxygen availability, media, o activity 
nitifying, active, no media (Y8) 80 
oxygen availability, n+o activity, 
settling 
nitrifying, active (Y2) 90 
oxygen availability, media, n+o 
activity 
nitrifying, active (Y3) 91 
oxygen availability, media, n+o 
activity 
 
Overall difference, nitrifying vs. inhibited 
avg. of duplicates 
% 
removal rel. % diff 
inhibited, active 70 26 
nitrifying, active 90 1 
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Table 34 - interpretation of triclosan results for Y-series samples. 
 
% of 
source % removal 
Reservoir 1 (F1.1) 100 0 
nitrifying, autoclaved (Y1) 45 55 
nitrifying, active (Y2) 25 75 
nitrifying, active (Y3) 31 69 
inhibited, autoclaved (Y4) 55 45 
inhibited, active (Y5) 44 56 
inhibited, active (Y6) 68 32 
nitrifying, autoclaved, no media (Y7) 179 -79 
nitifying, active, no media (Y8) 59 41 
 
Sorted by removal, least to most 
nitrifying, autoclaved, no media 
(Y7) -79 oxygen availability, settling 
inhibited, active (Y6) 32 oxygen availability, media, o activity 
nitifying, active, no media (Y8) 41 
oxygen availability, n+o activity, 
settling 
inhibited, autoclaved (Y4) 45 oxygen availability, media 
nitrifying, autoclaved (Y1) 55 oxygen availability, media 
inhibited, active (Y5) 56 oxygen availability, media, o activity 
nitrifying, active (Y3) 69 
oxygen availability, media, n+o 
activity 
nitrifying, active (Y2) 75 
oxygen availability, media, n+o 
activity 
 
Overall difference, nitrifying vs. 
inhibited 
avg. of 
duplicates 
% 
removal 
rel. % 
diff 
inhibited, active 44 55 
nitrifying, active 72 9 
 
 3.4.5 Discussion: F and Y-series samples 
F and Y-series results contrasted nitrification inhibited and uninhibited systems’ 
capacity for micropollutant removal. Unlike the E-series experimental procedure, F-series 
samples were collected in two events, to incorporate a control and treatment measurement into 
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the column study element of the project (Tables 29-31), in addition to the incremental 
treatment vs. control strategy employed in batch studies (Tables 32-34). This introduces a 
certain amount of problematic time continuity concerns as the comparison between the two 
sample subseries series contrasts not only uninhibited vs. inhibited, but also less vs. more 
acclimated column system performance, since the inhibited column system had been in 
operation five days longer than the uninhibited column system. However, with that caveat the 
comparison is still relevant as batch study conclusions are only so relevant to the column 
system.  
 FX.1 samples were generally as expected except that a more pronounced elevation of 
target compound concentrations in anaerobic column samples was observed in results for each 
analyte. However, a downward trend and good removal efficiency characterize the data (Figure 
40). FX.2 results for all analytes were not at all as expected, with a strong upward trend from 
the hypoxic column sample onward for estradiol, oscillating concentrations of triclosan 
throughout, and generally low concentrations of caffeine (Figure 41). As stated in results, a 
refill commensurate with the initiation of contact time for inhibited samples visually appeared 
to introduce source water with significantly different turbidity and presumably altered 
micropollutant load as well. The displacement of less settled, more turbid water (as observed) by 
a more clarified effluent completely in the first column, then to a decreasing extent from there 
onward would largely explain the pattern of estradiol, and perhaps triclosan as well. Caffeine 
concentration being less subject to this effect is consistent with its much higher solubility and 
decreased interaction with organic wastewater content. This hypothesis is consistent with TOC 
(Figure 37) and TN (Figure 38) data, which show trends similar to that observed in estradiol 
and triclosan. 
 Several conclusions are suggested by these findings. The significant clarification of 
source water that is allowed to sit for any period of time without agitation is an issue that can 
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skew results to the extent that they are unusable. The same principle applies to partially treated 
waters, from which a significant particulate or dissolved load was observed to separate and 
congeal on the bottom and sides of reservoirs, producing removal that is decoupled from 
experimental inputs and undesirable. To ensure that samples from different stages of treatment 
are comparable, and to avoid distortion of source water, agitation needs to be incorporated into 
the system design. Perhaps stirrer bars could be added and plates placed underneath each 
reservoir and also utilized during any storage of wastewater, or alternately the entire reservoirs 
could be kept in motion by a shaker of some kind, as with the batch studies. Content in the 
wastewater initially must be kept in suspension to produce meaningful results. 
 Secondly, the complete distribution of treatments and water of like origin is key to 
continuity throughout the column system. Water levels in reservoir between columns dilute 
spike levels initially, until water in these reservoirs is fully displaced. More thorough spiking of 
each reservoir was applied for G-series treatment (described in section 3.5.4 pertaining to that 
series); in addition to the measures taken for that series, it is advisable to allow greater amounts 
of time for contact, so that spiked chemicals are evenly and completely distributed throughout 
column media and then time is allowed for a biological reaction to manifest. This would also 
allow conditions to return to equilibrium states in the column system following the disruption 
involved in refilling and spiking system reservoirs. Time pressures did not allow for the luxury of 
providing excess acclimatization or contact times during the experiments described herein, but 
less abbreviated column system development is important to produce conditions in which a 
clear and accurate indication of treatment effect can be documented. While FX.1 column system 
results seem to overall reflect a column system that is functioning and contains an effective 
combination of wastewater treatment mechanisms, FX.2 samples were too distorted by 
operational complications to be used for comparison or to allow evaluation of the effect of 
nitrification inhibition. 
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 Batch study reaction vessels that were refilled using that same clarified wastewater are 
nonetheless internally consistent and controlled in a way that allows for evaluation of effect. 
Basic predictions held true: autoclaving and lack of media resulted in reduced removal efficiency 
compared with biologically active batches where water was in contact with media (Tables 32-
34). Between active nitrifying batches and active inhibited batches, the nitrifying batches were 
observed to have a slightly higher removal efficiency on average for estradiol, but the differences 
between duplicate batches and their overlap indicates that this effect is negligible. To better 
resolve the effect of nitrification on estradiol, this study would need to be repeated with 
extended acclimatization periods to further develop the biofilm under examination, and the 
number of batches would need to be increased to ameliorate the obscuring effect of variation 
inherent to this type of study, and to quantify degree of uncertainty in a meaningful way. 
 Despite inconclusive results pertaining to estradiol, a much more significant 
correlation was observed with regards to caffeine and triclosan. Especially given that this is 
unexpected for caffeine (though lack of literature linking caffeine degradation to nitrification in 
no way demonstrates that caffeine degradation is not linked with nitrification), these results 
must be considered preliminary and to be insufficient to conclusively demonstrate an effect. 
However, duplicate batches did not overlap, and relative percent differences between duplicates 
do not invalidate the difference in between average values. As stated previously, estradiol 
concentrations and sensitivity of analysis make results for that analyte the most erratic, and it is 
therefore not surprising that if issues with variability are experienced, they would be most 
pronounced for estradiol. 
3.5 G-series column study and X-series batch studies 
The final sampling event investigated triclosan’s hypothesized inhibition of nitrification. 
Following the F-series sampling event, the column system was broken down, substrate was 
again discarded, and the system was repacked, reestablished and reacclimatized by flowing fresh 
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wastewater for two weeks. On 8.3.11, the first of the two G-series system sample sets were 
collected (GX.1). Each reservoir was then spiked with triclosan elevating the concentration 10 
µg/L above background levels. The system was run for 5 days, and GX.2 system samples were 
collected on 8.8.11. 
The final batch study series was allowed to acclimatize from 7.22.11 until 8.3.11, and then 
spiked with 10 µg/L triclosan for the treatment set, and an unspiked control set was maintained 
alongside on the shaker. The batches were sampled on 8.8.11, with sample designations X1-8. 
Table 35 identifies sample labels with batch treatments, spiked in this instance referring to the 
addition of 10 µg/L triclosan. Nitrifying bacteria are not isolated in this experimental series; 
activity pertains to the entire microbial consortium, and autoclaved batches are assumed to be 
biologically inert. An unspiked, active no media aliquot (would have been X8) was not included 
in this series because insufficient distinction existed in practice between this data point and 
Reservoir 1 samples, in terms of treatment. 
Table 35 - Identification of sample labels with batch treatments. 
X1= unspiked, autoclaved 
X2= unspiked, active 
X3= unspiked, active 
X4= spiked, autoclaved 
X5= spiked, active 
X6= spiked, active 
X7= 
unspiked, autoclaved, no 
media 
 
3.5.1 Dissolved oxygen in columns and batches 
DO during the acclimatization and contact time for these studies was measured in the 
column system on 8.3.11; results are presented in Table 36. Batch study DO was measured on 
7.29.11 and the results are presented in Table 37. DO data distributed among the results from 
each series are compiled in Appendix C. 
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Table 36 - DO in column system, 8.3.11 (mg/L). 
Date Reservoir 1 Hypoxic Anaerobic Aerobic 
8.3.11 2.25 1.07 1.96 4.35 
 
Table 37 - DO in batch studies, 7.29.11 (mg/L). 
Date X1 X2 X3 X4 X5 X6 
7.29.11 4.09 3.79 4.15 3.66 3.93 4.00 
 
 3.5.2 Organic carbon in columns and batch studies 
 TOC was quantified in 1:100 dilutions of G and X-series samples. Results are presented 
in Table 38. These measurements are presented graphically as Figures 43-45.  
Table 38 - TOC in G and X-series samples (mg/L as C). 
 
TOC in 1:100 
dilution 
TOC dilution 
corrected 
G.1.1 0.4267 42.7 
G.2.1 0.324 32.4 
G.3.1 0.2691 26.9 
G.4.1 0.3102 31 
   
G.1.2 0.5265 52.7 
G.2.2 0.3832 38.3 
G.3.2 0.54 54 
G.4.2 0.01851 1.85 
   
X1 0.7353 73.5 
X2 0.4474 44.7 
X3 0.65 65 
X4 0.01851 1.85 
X5 0.5981 59.8 
X6 1.366 137 
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Figure 43 - TOC data from GX.1 samples. 
 
 
Figure 44 - TOC data from GX.2 column samples. 
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Figure 45 - TOC data from X-series batch samples. 
 
 3.5.3 TN in columns and batch studies 
 TN was also quantified in 1:100 dilutions of G and X-series samples, with results in 
Table 39. These measurements are presented graphically as Figures 46-48.  
Table 39 - TN results for G and X-series samples (mg/L as N). 
 
TN in 1:100 
dilution 
TN 
(dilution 
corrected) 
G.1.1 0.4605 46.1 
G.2.1 0.4393 43.9 
G.3.1 0.4609 46.1 
G.4.1 0.4424 44.2 
   
G.1.2 0.4746 47.5 
G.2.2 0.4665 46.7 
G.3.2 0.5092 50.9 
G.4.2 0.0405 4.05 
   
X1 0.5934 59.3 
X2 0.3776 37.8 
X3 0.5531 55.3 
X4 0.0405 4.05 
X5 0.2862 28.6 
X6 0.4096 41 
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Figure 46 - TN results for GX.1 column samples. 
 
 
Figure 47 - TN results for GX.2 column samples. 
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Figure 48 – TN results for X-series batch samples. 
 
 3.5.4 Bioassay results 
 Results of Abraxis analysis are presented in Table 40. Color coding identifies whether 
a three or four parameter curve was fit to the calibration points from which to interpolate 
unknowns.  
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Table 40 - G-series column system and X-series batch study results from Abraxis analysis. 
Sample ID 
Estradiol 
(ng/L) Caffeine (µg/L) Triclosan (µg/L) 
X1 30 3.1 0.6 
X2 10 2.0 0.4 
X3 15 3.2 0.4 
X4 23 8.6 1.6 
X5 15 5.4 1.3 
X6 23 9.0 4.6 
X7 114 45.0 1.8 
G1.1 44 39.3 1.2 
G2.1 166 32.6 3.9 
G3.1 54 29.0 0.4 
G4.1 43 3.8 0.4 
G1.2 47 42.4 10.5 
G2.2 100 29.6 1.9 
G3.2 66 23.9 6.7 
G4.2 16 3.1 2.2 
    
  <-- 4-param 
  
<-- less than 
values 
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Dilution factors were selected based on the results of the previous series of samples and 
adjusted based on anticipated alterations in treatment, and encroachments on upper and lower 
bounds to the range in which absorbance values could be quantified during previous sample 
series. Table 41 lists dilution factors for G-series 
column study samples and X-series batch studies. 
 Correction for dilution has already been 
applied to the values in Table 40 above. The 
corrected results are visually presented in Figures 
49-51. Subset graphs clarify the trends for analytes 
where their trend was obscured in combined figures 
due to incompatible scales. In GX.1 system samples, 
concentrations of estradiol and triclosan were elevated 
such that there was an increase from G1.1 to G2.1, 
opposed to the overall downward trend. In GX.2 
samples, a similar pattern was observed in estradiol 
data, and triclosan increased slightly from G2.2 to 
G3.2 but fluctuation was not dramatic. 
  
 
Table 41 - Dilution factors for G-series column 
system and X-series batch study samples for 
Abraxis analysis. 
Sample Dilution factor 
X1 10 
X2 5 
X3 5 
X4 10 
X5 5 
X6 5 
X7 20 
G1.1 20 
G2.1 10 
G3.1 5 
G4.1 5 
G1.2 20 
G2.2 10 
G3.2 5 
G4.2 5 
 
 
105 
 
 
 
Figure 49 - GX.1 sample concentrations of triclosan. 
 
 
Figure 50 - GX.2 sample concentrations of targeted analytes. 
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After issues in E-series samples with incomplete flushing of refill water and associated 
analyte concentrations throughout the column system, spikes were made differently in this 
experimental series. Firstly, volumes of water in Reservoirs 2 and 3 were reduced to the 
minimum workable level by increasing the flow rate through the anaerobic and aerobic columns 
relative to the hypoxic. Then, instead of spiking Reservoir 1 alone and relying on flow to carry 
the compound through the system, spikes were made into each reservoir, such that all water in 
the system (with the exception of that actually inside the columns at the time) was spiked  at a 
10 µg/L triclosan level.  
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Figure 51 - X-series sample concentrations (µg/L). 
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 Interpretation of this data is provided in Tables 42-47. Increases in concentration are 
highlighted; yellow highlighting was used for column system samples, blue for batches as the 
explanation for increases differs between the two. Green highlighting again indicates an 
opposite trend, so percent of source calculations based on those values represent maximums 
and percent removal values represent minimums. In batches, the qualifier spiked in this 
instance refers to the addition of 10 µg/L triclosan.  
 An additional interpretive step is taken where the difference between treatment and 
control samples that correspond is quantified for batch studies. As spiked and unspiked active 
batches were run in duplicate, their values were averaged for comparison, with the disparity 
between duplicates quantified in terms of relative percent difference. 
Table 42 - Interpretation of estradiol results for G-series samples. 
 
Sample % of source % removal % of prior 
G1.1 100 0  
G2.1 379 -279 379 
G3.1 122 -22 32 
G4.1 99 1 81 
    
G1.2 100 0  
G2.2 211 -111 211 
G3.2 139 -39 66 
G4.2 33 67 24 
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Table 43 - Interpretation of caffeine results for G-series samples. 
 
Caffeine % of source % removal % of prior 
G1.1 100 0  
G2.1 83 17 83 
G3.1 74 26 89 
G4.1 10 90 13 
    
G1.2 100 0  
G2.2 70 30 70 
G3.2 56 44 81 
G4.2 7 93 13 
 
Table 44 - Interpretation of triclosan results for G-series samples. 
 
Sample % of source % removal % of prior 
G1.1 100 0  
G2.1 326 -226 326 
G3.1 36 64 11 
G4.1 31 69 87 
    
G1.2 100 0  
G2.2 18 82 18 
G3.2 63 37 358 
G4.2 21 79 32 
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Table 45 - Interpretation of estradiol results for X-series samples. 
 
Sample % of source % removal 
Reservoir 1 (G1.1) 100 0 
unspiked, autoclaved (X1) 63 37 
unspiked, active (X2) 22 78 
unspiked, active (X3) 32 68 
spiked, autoclaved (X4) 48 52 
spiked, active (X5) 32 68 
spiked, active (X6) 48 52 
unspiked, autoclaved, no media (X7) 241 -141 
 
Sorted by removal, least to most 
unspiked, autoclaved, no media (X7) -141 oxygen availability, settling 
Reservoir 1 (G1.1) 0  
unspiked, autoclaved (X1) 37 oxygen availability, media 
spiked, active (X6) 52 
oxygen availability, media, 
activity 
spiked, autoclaved (X4) 52 oxygen availability, media 
unspiked, active (X3) 68 
oxygen availability, media, 
activity 
spiked, active (X5) 68 
oxygen availability, media, 
activity 
unspiked, active (X2) 78 
oxygen availability, media, 
activity 
 
Overall difference, spiked vs. unspiked 
avg. of 
duplicates 
% 
removal rel. % diff 
spiked, active 60 28 
unspiked, active 73 14 
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Table 46 - Interpretation of caffeine results for X-series samples. 
 
Sample % of source % removal 
Reservoir 1 (G1.1) 100 0 
unspiked, autoclaved (X1) 7 93 
unspiked, active (X2) 5 95 
unspiked, active (X3) 8 92 
spiked, autoclaved (X4) 20 80 
spiked, active (X5) 13 87 
spiked, active (X6) 21 79 
unspiked, autoclaved, no media 
(X7) 106 -6 
 
Sorted by removal, least to most 
unspiked, autoclaved, no media (X7) -6 oxygen availability, settling 
spiked, active (X6) 79 oxygen availability, media, activity 
spiked, autoclaved (X4) 80 oxygen availability, media 
spiked, active (X5) 87 oxygen availability, media, activity 
unspiked, active (X3) 92 oxygen availability, media, activity 
unspiked, autoclaved (X1) 93 oxygen availability, media 
unspiked, active (X2) 95 oxygen availability, media, activity 
 
Overall difference, spiked vs. unspiked 
avg. of 
duplicates 
% 
removal rel. % diff 
spiked, active 83 10 
unspiked, active 94 3 
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Table 47 - Interpretation of triclosan results for X-series samples. 
 
Sample % of source % removal 
Reservoir 1 (G1.1) 100 0 
unspiked, autoclaved (X1) 5 95 
unspiked, active (X2) 4 96 
unspiked, active (X3) 4 96 
spiked, autoclaved (X4) 16 84 
spiked, active (X5) 13 87 
spiked, active (X6) 43 57 
unspiked, autoclaved, no media 
(X7) 17 83 
 
Sorted by removal, least to most 
spiked, active 57 oxygen availability, media, activity, spike 
unspiked, autoclaved, no media 83 oxygen availability, settling 
spiked, autoclaved 84 oxygen availability, media, spike 
spiked, active 87 oxygen availability, media, activity, spike 
unspiked, autoclaved 95 oxygen availability, media 
unspiked, active 96 oxygen availability, media, activity 
unspiked, active 96 oxygen availability, media, activity 
 
Overall difference, spiked vs. unspiked 
avg. of 
duplicates 
% 
removal 
rel. % 
diff 
spiked, active 72 42 
unspiked, active 96 0 
 
 
 3.5.5 Discussion: G and X-series samples 
G and X-series samples were intended to validate on the capacity of triclosan to inhibit 
nitrification, thereby reducing the removal efficiency of estradiol. Format was identical to F and 
Y-series experiments with the exception of batch study aliquots maintained off the shaker- while 
both autoclaved and active aliquots were utilized previously, in X-series studies the active 
aliquot was discontinued (Table 35) as its function was similar to the Reservoir 1 sample used 
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for normalization, and the ways in which it differed from that sample were unidentified. In both 
Reservoir 1 and active no media batches, some oxygen was inadvertently introduced, but it is 
unknown which received more oxygen and therefore no treatment can be correlated with 
differences between the two. 
 In G-series samples, both GX.1 and GX.2, consistency issues again disrupted 
progressive treatment from being quantified from one column to the next. In GX.1 samples, a 
major increase in estradiol and triclosan concentrations occurred from the source to hypoxic 
column samples, following which concentrations decreased throughout anaerobic and aerobic 
column samples (Figure 49). The difference in behavior from estradiol and triclosan to caffeine 
indicates that the issue was again related to association of target compounds with organic 
content as in FX.2 samples. In GX.2 samples estradiol concentration increased to peak in 
hypoxic column samples, then declined, while caffeine concentration declined steadily (Figure 
50). Triclosan concentrations were used as an input and were largely artificial; concentrations 
were not expected to reflect removal efficiencies in this instance. It would appear that during G-
series sampling, source water contained high levels of target compounds relative to the previous 
water flowing through the system, so concentrations were elevated in early system stages rather 
than later ones. Again, because overall trends are not consistent with the basic conception of this 
as a treatment system where a source water of essentially fixed composition over time is subject 
to increasingly high degrees of treatment and removal of target compounds, no extrapolation of 
information regarding the effectiveness of triclosan as a nitrification inhibitor is possible. 
 Again though, issues that confound successful operation of the column system do not 
preclude effective batch study execution. Unfortunately, Abraxis analysis was unable to 
interpolate several estradiol concentrations in X-series samples due to their being marginal 
relative to the standard curve, but “less-than” values were inserted to allow for interpretation 
(Table 40). This should indicate that the gap between spiked and unspiked batches was in fact 
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larger than it appears, as maximum values were used in place of actual quantification values. 
The average unspiked, active removal rate was substantially higher than the average spiked, 
active removal rate, but as one of each pair of duplicates fell below the range of quantification 
this value is effectively based on one batch from each group, which reduces its reliability (Table 
45). Caffeine removal was higher in unspiked batches by a margin that is substantially larger 
than the relative percent differences in duplicates are able to account for (Table 46). However, 
the presence of an autoclaved batch in the top three sorted by removal rates indicates that 
physical treatment may have played a major part in caffeine removals, a hypothesis made more 
likely by the fairly tight grouping of all batches with media relative to the two reference samples 
without. Triclosan as stated before was not a dependent variable in this scenario. However, 
results for triclosan are entirely consistent with predictions as far as relative final concentrations 
in spiked and unspiked batches, with biological activity clearly corresponding to removal. 
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4. CONCLUSIONS 
 
4.1 Indications from Results 
 The research questions that originally prompted this project were: can removal of 
estradiol be correlated with aerobic treatment, and more specifically with nitrifying 
microbes, and secondly does triclosan inhibit nitrification? However, during the initial 
literature survey and preliminary efforts to put together an experimental design, it became 
evident that there are not readymade methods for exploring these concepts, leading to a 
reconception of the project as primarily concerned with design. Column and batch 
methodology is derived from previous work, but the use of packed soil columns for dynamic 
flow experiments where equilibrium conditions are assessed breaks with the majority of the 
literature, and the marginal treatment of batch studies constitutes an original approach as 
well. This being the case, refinements were suggested on an ongoing basis by analytical 
results and so the consistent execution of experiments capable of producing defensible 
evidence characterizing the fundamental forces at work has taken a back seat to 
improvement of the experimental design, by necessity. Findings are thought to be illustrative 
of the underlying mechanisms involved in the interrelated removals of micropollutants from 
wastewater, and those findings are presented here to inform future research. Yet, the 
limitations placed on statistical certainty and the modifying observations made regarding 
behavior of the column and batch systems must be recognized and carefully documented as 
well. Below, indications regarding micropollutant dynamics are summarized and compared 
with the conclusions made in the literature from prior research. A critical review of the 
conflicting and inconclusive elements of the research follows. From those, recommendations 
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are made as to what future research is suggested, what pertinent research questions are 
amenable to investigation using the models and methods described herein, and the 
implications of this work are discussed. 
 In the E and Z-series studies, baseline rates of removal were assessed. In the column 
system all analytes were removed at an approximately constant rate during treatment in 
each column. This is somewhat at odds with the hypothesis that removal of target 
compounds is more pronounced during aerobic treatment (Suarez et al. 2010). A likely 
explanation is that due to short start-up times, the finite capacity of the system substrate to 
remove micropollutants through sorbtion and physical sequestration was at a maximum 
while biologically mediated treatment was underexpressed as the development of biomass 
was incomplete. A more substantial acclimatization period would be likely to result in a 
more apparent bias towards aerobic removal of analytes. 
 The purpose of the batch studies was to subdivide aerobic treatment into chemical, 
physical and biological components, providing a more in-depth look at the factors 
responsible for the analyte removals observed in the column system. Z-series results 
demonstrated that biological treatment played a major role with respect to estradiol; 
removal rates for biologically inactive batches ranged from 22 to 69% compared with 79 to 
94% removal in active batches (Table 23). Caffeine removals were similar, ranging from -48 
(normalized to anaerobic, active source water) to 35% for inactive batches as opposed to 92 
to 99% in biologically active batches. Triclosan was removed 57 to 72% by inactive treatment 
versus 72 to 86% by active treatment. For all analytes, biologically-catalyzed removal plays a 
major role in efficacy of treatment. 
 Inhibition of nitrifier activity was imposed on batch and column studies and compared 
with nitrifying controls. In the inhibited column study, settled source water intermingled 
with agitated water and influenced the distribution of target compounds within the column 
system to the point that the removal efficiencies were imperceptible. Batch studies 
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succeeded in providing information that itemized the factors involved in aerobic treatment. 
For all analytes, biological activity again significantly improved treatment, but this was not 
the focus of this batch study iteration. The effect of selective inhibition of nitrification on 
estradiol removal was negligible (81% for inhibited, versus 85% in uninhibited batches), in 
contrast with results published in the literature. In caffeine results, uninhibited treatment 
resulting in 90% removal compared to 70% removal in inhibited batches. The spread was 
even more pronounced in triclosan results; 44% average removal in uninhibited as 
compared with 72% in nitrifying batches. 
 During the final column and batch experiments, the effect of triclosan on the removal 
of E2 and caffeine was assessed by dosing both with a 10 µg/L spike in order to compare 
removal rates with that of controls. It should be noted that the concentration of triclosan 
used here was more than 100,000-fold lower than the allylthiourea dose applied in previous 
experiments. The allylthiourea dosage had been suggested by the literature to produce a 
complete and instantaneous result, which was desired because this series was intended to 
reflect 100% inhibition of nitrifying bacteria. Triclosan dosage was chosen so as to be high 
enough that a response would potentially be pronounced enough to measure, but the 
concentration would still be environmentally relevant. Triclosan removal itself was not 
quantifiable during this series because concentrations are artificial. Average estradiol 
removal was 73% in unspiked batches, compared with 60% in spiked. Caffeine was removed 
by 94% percent removal in unspiked batches, 11% higher than in spiked. The triclosan dose 
was consumed to a large extent; the maximum final concentration was 4.6 µg/L, and the 
average in spiked batches was 2.5. 
 While variability of duplicate results raises questions about the significance of observed 
trends, in every instance the experimental hypotheses were borne out. Estradiol removal was 
higher in an aerobic, biologically active setting and reduced when nitrification was inhibited. 
Elevation of triclosan concentration also led to decreased estradiol removal, which is both 
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consistent with the previous hypothesis, and an indication that triclosan had a suppressive 
effect on biological treatment. Furthermore, triclosan removal was impaired by suppression 
of nitrification, which is a newer and less tested hypothesis in the literature, and caffeine 
also responded to fluctuations in the activity of nitrifiers, which was not predicted but is a 
concept not incompatible with the current understanding of caffeine removal. 
 This internally consistent outcome argues strongly for scale-up which would allow 
effects to be determined conclusively, to a standard capable of holding up to peer review. 
The tandem column studies are valuable for more closely relating efficiencies to actual 
treatment systems, demonstrating the relative importance of an aerobic environment, and 
for investigating dynamic equilibrium conditions, as opposed to decay constants. To 
overcome distortion of results related to organic-dependent distribution of analytes within 
columns and reservoirs, and in storage containers, agitation must be employed to keep 
target compounds in suspension. This fairly simple initiative would overcome an obstacle 
that obfuscated a significant portion of results from this project, enabling production of a 
more complete and convincing sample set. 
 Another important future modification would be the inclusion of the estrone ELISA 
analysis. As of now, estrone will test as 75% estradiol in wastewater samples according to the 
manufacturer. As estrone is a degradation product of estradiol during abiotic 
transformation, the estradiol Abraxis kit will tend to underestimate the importance of 
physical treatment and overestimate microbial removal. The separation of treatment factors 
is a central element of this experimental design. The two kits used together should be 
capable of distinguishing the two compounds through correction, even with some cross-
reactivity. 
 A final overarching conclusion is that baseline conditions constitute a treatment, a 
dosage of micropollutants, and the effect of that dosage cannot be ignored. Perhaps removal 
of estradiol did not vary more from uninhibited to inhibited nitrifier batches because all 
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batches were already significantly inhibited by triclosan. This is a difficult problem to 
circumvent, but this may be another reason why onsite systems are conducive to this line of 
research. Though it would be impossible to modify the wastewater entering a municipal 
treatment works for research purposes, the CCCC is a relatively small facility and triclosan, 
or other compounds of concern, could be prevented from entering the wastewater in the first 
place by making arrangements with users and with the administration. Triclosan in cleaning 
agents and soaps is replaceable and alternatives exist. Experiments that are able to compare 
treatment with a true control, with a dose of zero would eliminate a weakness in concept that 
is potentially extremely influential to conclusions that are drawn. 
 
4.2 Suggestions for Future Research 
  A wide range of research topics are suggested by this project. Obviously there is room 
to continue in the same vein in order to substantiate the hypotheses embedded in this thesis. 
In addition, the same basic procedures could be expanded to investigate other 
micropollutants, most pressingly nonylphenol which is another suspected inhibitor of 
nitrification and also has physical properties likely to influence removal rates. Other 
compounds have been observed to be removed in aerobic conditions by biologically 
mediated transformation, such as ibuprofen, and these could be subjected to similar 
examination to determine their relationship with nitrifying bacteria. 
 Aside from simple correlation between inhibition and removal, there are other means 
of associating specific subsets of the microbial consortium present in any wastewater 
treatment context with metabolism of specific wastewater constituents. Tagging chemicals 
before they enter the column or batch system, with heavy or radioactive isotopes or other 
markers could then allow for the isolation of the organisms that bind that chemical, which 
coupled with DNA identification could much more definitely start to uncover what specific 
bacteria, protozoa, fungi, etc. can remediate target chemicals in wastewater. 
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 To improve the certainty that can be placed in ELISA results, the method should be 
subjected to a thorough validation using comparison with results of some sample analysis by 
GC-MS, which would relate ELISA results to those produced in the many studies where 
chromatography is the only analytical method involved. There would be significant method 
development involved to test comparable samples, to avoid eliminating target compounds 
with organic matter, but until that work is performed matrix interference and accuracy 
cannot be characterized, even in results with many replicates. 
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APPENDIX A – SCHEMATICS OF CCCC ONSITE WASTEWATER TREATMENT 
SYSTEM 
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APPENDIX B – PHOTOS OF COLUMN SYSTEM AND BATCH STUDIES 
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APPENDIX C – DISSOLVED OXYGEN 
 Dissolved oxygen measurements in the source wastewater and column effluents 
throughout the study are compiled in Table C1 below. These results were observed to be 
strongly influenced by disturbance of the reservoirs- taking samples to test for DO in reverse 
order, rather than starting with reservoir 1 results in considerably less inflated values. It is likely 
that during sample collection DO is added to water irregardless of sampling order, and so these 
results should be viewed as estimates, likely to be in excess of actual equilibrium values. 
Table C1 - Dissolved oxygen (mg/L) measurements in column system. 
Date Reservoir 1 Hypoxic column Anaerobic 
column 
Aerobic 
column 
2/16/11 2.75 2.95 4.98 5.10 
2/21/11 2.58 2.35 1.85 2.15 
3/2/11 0.98 3.41 1.65 3.04 
4/28/11 0.38 0.21 1.34 3.42 
4/29/11 0.32 0.17 0.11 2.96 
4/30/11 0.84 0.03 0.31 2.63 
5/1/11 0.08 0.70 0.0 3.38 
5/2/11 0.08 0.23 0.18 2.62 
5/5/11 0.0 0.14 0.0 1.31 
5/11/11 0.21 0.11 0.05 3.57 
5/16/11 1.06 0.07 0.03 4.03 
6/2/11 0.19 1.52 0.90 4.47 
7/6/11 1.71 0.78 0.12 1.28 
8/3/11 2.25 1.07 1.96 4.35 
 
Batch study DO measurements are tabulated below (Table C2). 
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Table C2 - Dissolved oxygen (mg/L) measurements in batch studies. 
Date Batch 1 Batch 2 Batch 3 Batch 4 Batch 5 Batch 6 
5.30.11 (Z) 0.00 0.07 0.11 3.62 4.16 0.73 
6.1.11 (Z) 4.55 4.50 4.30 4.63 4.85 4.45 
7.5.11 (Y) 4.37 4.58 4.45 4.83 4.19 4.38 
7.29.11 (X) 4.09 3.79 4.15 3.66 3.93 4.00 
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APPENDIX D – NITROGEN MEASUREMENTS 
 D-series samples were taken on 4.28.11 to assess the performance of the column system 
when nitrification was inhibited by allylthiourea. While these samples were carried through 
SPE, issues with application of the GC-MS prevented quantification of organic analyte 
concentrations in these samples. However, nitrogen species were repeatedly analyzed in order to 
determine whether rebound of nitrification capacity would take place within a logistically 
workable time frame. 
 Nitrogen species were assessed separately by Hach colorimetric testing kits, and total 
nitrogen was separately quantified using a Shimadzu TOC analyzer. Hach kit measurements are 
tabulated below; each data point is defined by the format duplicate 1 reading, duplicate 2 
reading (dilution corrected mean); all values are in mg/L. Table D1 presents the results of NH3 
measurement, which required 1:200 dilution. Initial readings were taken using a 1:1000 
dilution, which was reduced to 1:500 and then 1:200 as additional experimentation allowed for 
optimization of dilution factor. Table D2 presents the results of nitrite analysis using the Hach 
method, which can be applied to undiluted samples. Table D3 presents the results of nitrate 
analysis using the Hach method, also conducted without dilution.  
 Dud reagents are not uncommon with this technique especially as the materials 
approach their expiration date, causing some non-detects where the duplicate sample yields a 
significant value. In these instances the false negative values were discarded. 
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Table D1 - Ammonia (mg/L as N) concentrations in D-series samples. 
Date Reservoir 1 Hypoxic 
column 
Anaerobic 
column 
Aerobic column 
4/28/11 
(DX.1) 
0.08, 0.08 (80) 0.07, 0.07 (70) 0.15, 0.15 (75) 0.16, 0.16 (80) 
4/29/11 
(DX.2) 
0.31, 0.36 (67) 0.41, 0.42 (83) 0.27, 0.44 (71) 0.32, 0.43 (75) 
4/30/11 
(DX.3) 
0.52, 0.56 
(108) 
0.44, 0.46 (90) 0.54, 0.58 (112) 0.54, 0.59 (113) 
5/1/11 (DX.4) 0.33, 0.42 (75) 0.31, 0.43 (74) 0.38, 0.42 (80) 0.29, 0.42 (71) 
5/5/11 (DX.5) 0.13, 0.38 (46) 0.36, 0.28 (64) 0.22, 0.45 (67) 0.37, 0.20 (57) 
5/11/11 (DX.7) 0.39, 0.42 (81) 0.42, 0.40 (82) 0.44, 0.44 (88) 0.42, 0.37 (79) 
5/16/11 
(DX.8) 
0, 0 0, 0.34 (68) 0.32, 0.33 (65) 0, 0.31 (62) 
 
 
Table D2 - Nitrite (mg/L as N) concentrations in D-series samples. 
Date Reservoir 1 Hypoxic 
column 
Anaerobic 
column 
Aerobic column 
4/28/11 (DX.1) 0.0, 0.0 (0) 0.2, 0.7 (0.5) 1.9, 2.2 (2.1) 4.3, 3.2 (3.8) 
4/29/11 (DX.2) 0.4, 0.6 
(0.5) 
1.7, 1.4 (1.6) 1.8, 2.0 (1.9) 4.0, 4.1 (4.1) 
4/30/11 (DX.3) 1.5, 2.2 (1.9) 1.7, 1.1 (1.4) 2.3, 2.7 (2.5) 3.7, 4.5 (4.1) 
5/1/11 (DX.4) 0.6, 0.4 
(0.5) 
0.9, 1.1 (1.0) 5.9, 5.0 (5.5) 1.6, 1.7 (1.7) 
5/5/11 (DX.5) 1.8, 1.3 (1.6) 1.1, 0.8 (1.0) 1.1, 1.6 (1.4) 0.4, 0.5 (0.5) 
5/11/11 (DX.7) 2.2, 0 (2.2) 1.9, 0 (1.9) 3.9, 8.6 (6.3) 2.1, 2.1 (2.1) 
 
 
Table D3 - Nitrate (mg/L as N) concentrations in D-series samples. 
Date Reservoir 1 Hypoxic 
column 
Anaerobic 
column 
Aerobic column 
4/28/11 
(DX.1) 
0.0, 0.0 (0) 0.2, 0.7 (0.5) 1.9, 2.2 (2.1) 4.3, 3.2 (3.8) 
4/29/11 
(DX.2) 
0.4, 0.6 
(0.5) 
1.7, 1.4 (1.6) 1.8, 2.0 (1.9) 4.0, 4.1 (4.1) 
4/30/11 
(DX.3) 
1.5, 2.2 (1.9) 1.7, 1.1 (1.4) 2.3, 2.7 (2.5) 3.7, 4.5 (4.1) 
5/1/11 (DX.4) 0.6, 0.4 
(0.5) 
0.9, 1.1 (1.0) 5.9, 5.0 (5.5) 1.6, 1.7 (1.7) 
5/5/11 (DX.5) 1.8, 1.3 (1.6) 1.1, 0.8 (1.0) 1.1, 1.6 (1.4) 0.4, 0.5 (0.5) 
5/11/11 (DX.7) 2.2, 0 (2.2) 1.9, 0 (1.9) 3.9, 8.6 (6.3) 2.1, 2.1 (2.1) 
 
 
Nitrogen species measurements are displayed visually in Figure D1-D3 below. 
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Figure D1- Ammonia (mg/L as N) concentrations in D-series samples. 
 
Figure D2 - Nitrite (mg/L as N) concentrations in D-series samples. 
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Figure D3 - Nitrate (mg/L as N) concentration in D-series samples. 
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APPENDIX E – MICROBIOLOGICAL ANALYSIS 
 Assessing CFU counts in column system samples was a measure utilized early on in its 
operational history. Determination of whether a biofilm was established, whether it had reached 
a dynamic equilibrium point in buildup, and correlating presence of biofilm with observed 
removal rates were motivating objectives. Because a biofilm in this context would refer primarily 
to microorganisms attached to an immobile substrate, application of these methods that process 
an aqueous sample would require that an extraction be performed. Boehm et al. (2009) 
conducted a review of extraction methods from sand and determined optimal technique for 
extraction efficiency, findings that were applied to column materials to produce liquid samples 
amenable to filter-based methods. The extraction technique employed was conducted as follows. 
LGW is added to substrate at a 10:1 ratio (v:v) and shaken by hand for 2 minutes. A 30 second 
rest period follows, after which eluate is poured into a sample flask. One wash step is performed 
following the same procedure, using 100 mL of LGW, a reduced volume to avoid overdiluting 
the intial eluate. 
 Samples were found to be too sediment-laden to use in a filter plate application. A 4 
hour settling time was added, after which the supernatant was poured off and used for fecal 
coliform and heterotrophic plate count analyses. 
The following protocols are paraphrased from Standard Methods for the Examination of Water 
and Wastewater, 16th edition. 
Fecal coliform 
  Dehydrated medium is rehydrated with LGW containing 10mL 1% rosolic acid in 0.2N 
NaOH. This mixture is heated to boiling, then promptly removed from heat. 2 mL aliquots are 
dispensed into 50 x 9mm petri dishes. Medium is permitted to solidify at room temperature, 
then refrigerated in a plastic bag (Figure E1). Sample volume to be filtered is adjusted to give 
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20-60 CFU per filter. The selected volume is drawn through a sterile 47mm, 0.45 micron 
gridded membrane filter under partial vacuum. The funnel is rinsed with 30 mL LGW. Filters 
are applied to petri dishes such that the underside of the filter as oriented during filtration is in 
contact with the medium. Dishes are placed within a plastic bag and are incubated at 44.5° C for 
24h in a water bath, to ensure even distribution of heat. Results are presented as CFU/mL. 
Heterotrophic plate count 
 5 mL portions of sterile heterotrophic plate count medium are dispensed into 50 x 
9mm petri dishes. Medium is permitted to solidify at room temperature, then refrigerated in a 
plastic bag. Sample volume to be 
filtered is adjusted to give 20-200 
CFU per filter. The selected 
volume is drawn through a sterile 
47mm, 0.45 micron gridded 
membrane filter under partial 
vacuum. The funnel is rinsed with 
30 mL LGW. Filters are applied to 
petri dishes such that the 
underside of the filter as oriented 
during filtration is in contact with the medium. Dishes are placed within a plastic bag with a 
damp paper towel and are incubated at 35° C for 48h. Results are presented as CFU/mL. 
Shortcomings of these measures 
 Ultimately these methods were discontinued as a result of concerns regarding the 
ability of these measurements to adequately reflect the establishment of a biofilm, which 
consists of a diverse consortium of microorganisms not limited to the heterotrophic subset or 
Figure E1 - HPC and FC medium in petri dishes. 
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necessarily related to fecal indicator bacteria. If these measures were expected to remain 
proportional to the whole in each column system stage, the quantitative relationship would 
potentially be less important, but the relative proportion of microorganisms belonging to the 
heterotrophic subset is in all likelihood related to oxygen availability, and coliform count would 
be expected to decrease throughout treatment stages in a manner largely decoupled from 
biological activity. The implementation of batch studies featuring autoclaved contrasted with 
non-autoclaved batches was a design element offering a more elegant and robust means of 
dealing with the research objectives leading to the use of filter plate methods in the first place, 
and so that design feature effectively invalidated the need to continue with those techniques. 
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APPENDIX F – KNOWN ADDITION IN SAMPLES ANALYZED USING 
CHROMATOGRAPHIC METHODS 
 In order to convert ion count values produced by the GC-ECD to concentration data, 
standard addition aliquots were made up for B1, B4, C1 and C4. These were chosen in order to 
screen for matrix effects, which would likely be more pronounced in untreated B1 and C1 
samples and could potentially cause the ratio of ion counts to compound concentration to be 
variable depending on co-contaminant levels in the sample. Each sample was split into an 
unspiked aliquot and two calibration samples, Cal-1 being spiked with 100 µL in a 500 mL 
sample volume, of a mixed standard solution containing estradiol, caffeine, triclosan, estrone, 
ibuprofen and nonylphenol at 10mg/L each (+5 µg), and Cal-2 spiked with 200 µL of the same 
solution (+ 10 µg). 
 Results from Abraxis analysis of these calibration points are presented as Tables F1 
and F2. Results from GC-ECD analysis of these calibration points are presented as Table F3. 
Table F1 - Estradiol results for B and C-series samples from Abraxis, with calibration points. 
 
Sample 
Dilution corrected 
(ng/L) 
B1 US-1 325 
B1 Cal-1 415 
B1 Cal-2 344 
B4 US-1 115 
B4 Cal-1 222 
B4 Cal-2 218 
C1 US-1 160 
C1 Cal-1 436 
C1 Cal-2 435 
C4 US-1 76 
C4 Cal-1 433 
C4 Cal-2 434 
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Table F2 - Triclosan results for B and C-series samples from Abraxis, with calibration points. 
 
Sample Dilution corrected (ug/l) 
B1 US-1 546.7 
B1 Cal-1 681.0 
B1 Cal-2 1980.5 
B4 US-1 491.7 
B4 Cal-1 430.7 
B4 Cal-2 712.2 
C1 US-1 1431.2 
C1 Cal-1 29850.9 
C1 Cal-2 22311.1 
C4 US-1 462.7 
C4 Cal-1 9663.3 
C4 Cal-2 17666.4 
 
 
Table F3 - Triclosan results for B and C-series samples from GC-ECD, with calibration points. 
 
Sample 
Peak area (ion 
counts) 
B1 US-1 18412 
B1 Cal-1 13520 
B1 Cal-2 15126 
B4 US-1 2322 
B4 Cal-1 9505 
B4 Cal-2 11611 
C1 US-1 32870 
C1 Cal-1 37365 
C1 Cal-2 34503 
C4 US-1 14343 
C4 Cal-1 14712 
C4 Cal-2 14167 
 
 
 B and C-series results are visually presented as Figures F1-F3. As these tables and 
figures make apparent, the calibration curve did not resolve as a linear relationship between 
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spiked concentration and response. This being the case, it was not possible to ascertain a 
relationship between ion counts and concentration, with which to convert GC-ECD results to 
concentrations for comparison with Abraxis results.
 
Figure F1 - Estradiol data for B and C-series samples from Abraxis, with calibration points. 
 
Figure F2 - Triclosan results for B and C-series samples from Abraxis, with calibration points. 
0
50
100
150
200
250
300
350
400
450
500
B1 US-1 B1 Cal-1B1 Cal-2 B4 US-1 B4 Cal-1B4 Cal-2 C1 US-1 C1 Cal-1C1 Cal-2 C4 US-1 C4 Cal-1C4 Cal-2
0
5
10
15
20
25
30
35
B1 US-1 B1 Cal-1B1 Cal-2 B4 US-1 B4 Cal-1B4 Cal-2 C1 US-1 C1 Cal-1C1 Cal-2 C4 US-1 C4 Cal-1C4 Cal-2
139 
 
 
Figure F3 - Triclosan results for B and C-series samples from GC-ECD, with calibration points. 
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APPENDIX G – ABRAXIS DOCUMENTATION 
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APPENDIX H – APPLICATION OF ABRAXIS KITS TO WASTEWATER SAMPLES 
Preliminary Abraxis results were used to explore the nuances of fitting a curve to 
standard absorbances and interpolating concentrations of unknowns using GraphPad Prism. 
Absorbance values were converted to concentrations using a sigmoidal dose-response (variable 
slope) curve, which is described in GraphPad literature as being identical to the four-parameter 
logistic curve called for in Abraxis instructions. The fit of this curve (R2 value) tends to be 
greater than 0.98 when the curve is unconstrained. Having experimented with normalizing data 
to a 0-100 range and constraining the curve to pass through those endpoints, it would appear 
that an unconstrained curve offers a superior fit to the data.  
However, with these settings selected, data points are more likely to be rejected as 
outliers, in which case no concentration value is produced. This is acceptable for data points 
genuinely outside of the standard curve, where estimation would be useful for determination of 
subsequent dilution but a reasonable degree of certainty is clearly not possible. In some cases 
though, data points lying within one or even both of the duplicate boundary (high or low) 
standard points are also rejected. In these cases, utilizing a sigmoidal dose-response curve with 
a normal slope (otherwise known as a three-parameter logistic curve) allows determination of 
concentration based on a calibration curve which has a high degree of fit to standard data.  
Another aspect of this technique that has been investigated is the applicability of an 
initial standard curve to subsequent iterations of the assay using the same kit. It is assumed in 
Abraxis literature that calibration would need to be repeated for each new lot, but in theory it 
might be possible to repeat only two points from the initial standard curve, with which we could 
correct for any drift that was found to have occurred. The quality of results obtained in this way 
was evaluated by using full standard curves from the same kit produced on two consecutive 
days. Unknowns from the second day were interpolated based on the full standard curve from 
that day, then interpolated based on the full standard curve from the previous day and “drift 
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corrected” based on two points from the second day’s standard curve. Drift correction involved 
taking the difference between concentration results for the same standard from the two different 
days, averaging them, and adding or subtracting that average difference to all unknowns.  
It was determined by comparing the values for unknowns quantified based on a 
correction determined using a two point standard curve with the “real” values based on the full, 
simultaneously assessed standard curve that drift does not take the form of a consistent 
absorbance increase or decrease across the concentration range, but rather would be 
represented by a curve that is stretched or compressed, in addition to being shifted up or down. 
This being the case, the error introduced by approximating this changing calibration curve using 
mathematical correction outweighs the reduced materials demand of conducting the assay in 
this way, and this approach has been discontinued. 
In the process of determining how and why drift takes place from day to day using the 
same materials and methods, the contribution of the plate reader to the overall drift in results 
was tested. A test plate was made up using LGW and methyl orange such that the absorbance 
range of the wells was roughly similar to that of Abraxis kit wells, at the time at which they are 
read. The test plate was read and then reread over time, initially without shutting down the plate 
reader, and then immediately before and after shut down, and after an overnight shutdown to 
determine what difference variables such as warm up period and shut down have on 
performance. It was observed that there is a consistent rate of drift to the readings taken, but 
that it is small relative to the change from day to day in Abraxis absorbance values for the same 
standard (0.025 vs. 0.5 absorbance units over 24 hours, respectively). A LGW blank did not 
change substantially; very small fluctuation in the uncertain decimal place could be indicative of 
drift that is proportional to absorbance (and therefore very small for a blank), or could be 
merely insignificant fluctuation. Changing blank readings did not progress in a linear fashion 
over time like other wells, indicating that they were most likely not drifting. The minor amount 
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of drift that was observed also likely represents an overestimate, as methyl orange is not totally 
stable and the color in the well was in fact not absolutely consistent from day to day. 
More recently recovery experiments were conducted in which known addition was used 
to investigate for the presence of matrix effects in the data set. Concentrations of each analyte 
were increased by amounts dictated by lower and upper limits of detection for each kit: 5 and 10 
ng/L for estradiol, 0.5 and 1.0 µg/L for caffeine, and 2 µg/L for triclosan. The estradiol and 
caffeine known addition results span the detection range, whereas triclosan known addition was 
used to produce four similar samples so variance could be quantified. Recoveries show a high 
degree of correlation with spike concentrations, but the accuracy is lower than expected. It is 
likely that much of this variance results from the dilution involved in producing the target spike 
concentrations, a hypothesis that can be tested by comparing these known addition results with 
the standard deviation of four unspiked samples from the same source. Dilution techniques may 
need to be refined if it is found that spiked concentrations are not proportionally accurate post-
dilution; due to matrix effects on partitioning of spiked volumes, preparation of 5 or 10 ng/L 
solutions may need to take place separate from wastewater to as great of an extent as possible.  
 Establishment of the Abraxis method to analyze an onsite wastewater matrix and 
validation are described in general terms above. Key initiatives included development of dilution 
factors, repetition of the assay based on an abridged calibration curve, testing the drift in plate 
reader values, and recovery of known additions. All dilution factors, in chronological order are 
included below as Table H1.  
 
Table H1 - Compiled Abraxis dilution factors 
3.28.11 4.4.11 6.7.11 
Sample Dilution Sample Dilution Sample Dilution 
C4 US-1 filtered 10 B1 US-1 10 E1 20 
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C4 US-1 
unfiltered 10 
B2 US-
1 10 E2 20 
  
B3 US-
1 10 E3 10 
  
B4 US-
1 10 E4 10 
  C1 US-1 10 Z1 10 
  
C2 US-
1 10 Z2 10 
  
C3 US-
1 10 Z3 5 
  
C4 US-
1 10 Z4 10 
    Z5 5 
    Z6 20 
    Z7 5 
    Z8 10 
 
7.13.11 8.8.11 
Sample Dilution Sample Dilution 
F1.1 20 G1.1 20 
F2.1 20 G2.1 10 
F3.1 10 G3.1 5 
F4.1 10 G4.1 5 
F1.2 20 G1.2 20 
F2.2 20 G2.2 10 
F3.2 20 G3.2 5 
F4.2 20 G4.2 5 
Y1 10 X1 10 
Y2 5 X2 5 
Y3 5 X3 5 
Y4 10 X4 10 
Y5 10 X5 5 
Y6 10 X6 5 
Y7 20 X7 20 
Y8 10   
 
 The adjustment of prior calibration curves to interpolate new unknowns was assessed 
for error by running triclosan analysis two days in a row (6.6.11-6.7.11) with full calibration 
curves each time. The two standards used to adjust previous calibration curves were then pulled 
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from the second day and used to correct the first day’s curve. The results produced from this 
technique were then compared with the “true” results based off of a simultaneously run 
calibration curve as is called for by the procedure as described in the manufacturer’s literature. 
Variance in absorbance values for Abraxis standard curve wells are depicted in Figure H1; 
evaluation of drift correction discussed above is tabulated in Table H2. 
 
Figure H1 - Abraxis triclosan standard curve variation over time. 
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Table H2 - Comparison of drift-corrected triclosan results with "true" values. 
Sample 6.7.11 cal curve 6.6.11 cal curve 
relative % 
difference 
E2 1.2 2.1 58 
E3 1.0 2.3 79 
E4 0.6 1.9 106 
Z1 0.6 2.0 104 
Z2 0.7 2.0 96 
Z3 0.3 1.0 104 
Z4  1.5  
Z6 0.6 3.4 139 
Z7 0.5 1.2 75 
Z8 1.0 2.3 81 
 
 Drift in plate reader values was tested using a plate containing dilutions of methyl 
orange in LGW. The instrument was monitored while remaining on for 21.5 hours, then shut 
down to see what effect that would have on drift. Afterwards it was shut down overnight to cool 
completely, then powered back on and warmed up before a final reading was taken (Table H3, 
Figure H2). 
Table H3 - Consecutive absorbance readings of a methyl orange test plate over time. 
 On 5 min 
On 70 
min 
On 3 
hours On 21.5 hours 
22 hours, post-
shutdown 
48 hours, off 
overnight 
A1 0.031 0.031 0.031 0.032 0.030 0.032 
B1 0.031 0.031 0.031 0.031 0.031 0.031 
C1 0.030 0.031 0.030 0.031 0.031 0.031 
D1 0.031 0.031 0.031 0.031 0.031 0.032 
E1 0.531 0.526 0.518 0.476 0.473 0.468 
F1 0.276 0.274 0.271 0.259 0.258 0.258 
G1 0.748 0.740 0.735 0.710 0.711 0.699 
H1 0.773 0.769 0.765 0.694 0.694 0.685 
A2 0.821 0.814 0.809 0.765 0.766 0.754 
B2 0.774 0.766 0.763 0.738 0.736 0.713 
C2 0.838 0.826 0.821 0.694 0.687 0.675 
D2 0.806 0.796 0.789 0.448 0.542 0.517 
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Figure H2- Consecutive readings of a methyl orange test plate over time. 
 Known addition was employed in E-series samples to screen for matrix effects of the 
wastewater matrix, and to validate the use of the Abraxis technique. Duplicate wells were treated 
individually as the purpose was to look at variation in results produced for the same sample. 
Duplicates are then averaged in order to compare their individual variability with the variability 
involved when following the standard procedure, which averages duplicate wells to improve 
accuracy (Tables H4-H5). For estradiol and caffeine, two different addition levels were used to 
investigate varying response throughout the range of detection. In triclosan samples, four 
repetitions of the same spike level allowed a standard deviation value to be calculated, 
quantifying variability. Ideally these measures would have been individually conducted for each 
analyte and corresponding Abraxis materials, but limited resources dictated the use of this 
survey approach. 
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Table H4 - Interpretation of estradiol known addition. 
 
Spike 
(mg/L) ng/L Diff Recovery (%) 
+0 13   
+0 12   
+5 18 6 113 
+5 19 7 133 
+10 21 8 83 
+10 21 8 83 
 
Averaged duplicates 
ng/L Difference Recovery (%) 
12   
   
19 6 123 
   
21 8 83 
 
Table H5 - Interpretation of caffeine known addition. 
 
Spike ug/l Diff 
Recovery 
(%) 
+0 2.2   
+0 2.7   
+0.5 3.0 0.6 112 
+0.5 2.7 0.3 51 
+1.0 3.3 0.9 85 
+1.0 3.5 1.0 97 
 
Averaged duplicates 
ug/l Difference Recovery (%) 
2.4   
   
2.9 0 80 
   
3.4 1 91 
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Table H6 - interpretation of triclosan known addition. 
 
Spike 
(µg/L) ug/l Diff Recovery (%) 
+0 0.1   
+0 0.2   
+2 2.7 2.6 134 
+2 2.7 2.6 134 
+2 2.2 2.1 109 
+2 2.9 2.8 146 
 
Mean values 
 Diff Recovery (%) 
0.1   
   
2.7 2.6 134.0709 
   
2.6 2.4 126.3041 
 
Standard deviation  
Mean 
conc. Difference Difference sq.  
2.7 0.1 0.00   
2.7 0.1 0.00   
2.2 -0.4 0.17   
2.9 0.3 0.08   
2.6  0.06 0.252 <-- std. deviation 
 
 
Discussion of Abraxis method development and validation 
 Elements of method establishment and validation include determination of dilution 
factor, exploration of abridged standard curves and measurement of drift, and recovery of 
known additions.  
 The initial basis for choosing dilution factors was anticipated levels of estradiol in 
CCCC source water, which was approximated by looking up results in literature dealing with 
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similar source waters. This guess was tested during the Abraxis training session with C-series 
samples. That dilution luckily turned out to be appropriate and the sample fell within the range 
of detection. For each subsequent dilution, the predicted concentrations relative to previous 
experiments was considered and then dilution factors were adjusted to the next convenient 
option, typically choosing among 5, 10, 20 or 40x dilution. An unexpectedly fortuitous 
development discovered during initial analyses is that the ranges of detection for the Abraxis 
kits for the three target compounds are proportional to one another in a way that is very similar 
to the baseline concentrations of those compounds in environmental samples. This is helpful 
because one dilution of a sample can be analyzed by all three kits, without any need to dilute 
differently to adapt the sample to various ranges of detection. It would seem that the designers 
of these kits did a good job of anticipating typical environmental levels of occurrence and 
aligning their ranges of detection with those levels. Only in the G and X-series samples where 
triclosan had been spiked in at high levels were multiple dilutions required. 
 Abridged standard curves are a concept that would not be attempted by anyone 
following the Abraxis instructions closely, or who was accustomed to running antibody-based 
assays as the simultaneously produced calibration curve is a fixture in these analyses due to 
their inherent tendency to drift, even if the researcher is very careful to conduct the assay 
consistently. That said, resources were a serious enough limitation throughout the course of this 
project that this practice was attempted and assessed in order to try and stretch what materials 
were available a bit further. The comparison of “drift corrected” values with the results produced 
in accordance with Abraxis literature make clear that variance from day to day is not of a type 
that can be easily characterized and thus mathematically compensated (Table H7). Values are 
not off in a consistent way that could be dealt with through the application of a compensation 
factor. This assay incorporates enough variation and error following procedure that the 
additional loss of resolution that results from attempting to use abridged calibration curves is 
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not acceptable. This procedure was discontinued after the initial application, and it is not 
recommended for future use. 
 During the consideration of drift and standard curve specificity, the plate reader was 
tested to determine to what extent results drift as a consequence of changing plate reader 
response to well color. The test plate analysis was slightly flawed because the methyl orange 
used to produce stable color in fact likely changed over the course of the experiment slightly, 
and also some wells were altered between readings because removal of the plastic cover led to 
their being moved too sharply and some liquid was displaced. Even including some change over 
time that was not attributable to plate reader drift, the shifting readings for the same wells 
fluctuated much less than the observed change from day to day in response for the same Abraxis 
standard, indicating that the plate reader was not the primary source of drift in Abraxis results 
(Figure H6). Furthermore, this drift is irrelevant when assays are quantified using a standard 
curve that was read simultaneously, as called for in Abraxis instructions. 
 Known addition work would ideally reveal the presence of matrix effects, dependent on 
degree of dilution and location within the range of detection. In this case, the variation inherent 
in ELISA techniques mean that to actually demonstrate the presence of matrix effects, one 
would have to run large numbers of redundant samples because matrix interference would take 
the form of a tendency towards over-expression or under-expression rather than an ever-present 
factor of error. This was not possible, so like with other results the known addition is 
preliminary work that explores the viability of continuing evaluation of variables using the 
technique. The upshot of known addition was that estradiol spikes were reflected as having 
increased concentration more than and less than actual compound addition at different levels 
(Table H4), caffeine was consistently under-recovered (Table H5), and triclosan was 
consistently over-recovered (Table H6). Standard deviation of four repetitions of triclosan-
spiked samples was 0.252 ug/l, which is significant (and is multiplied by dilution) but generally 
does not obscure the correlations identified in batch study results. One note regarding the 
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known addition results is that various analyte spikes were made into the same samples, so any 
cross-reactivity between target compounds during Abraxis analysis would be included in these 
results. Cross-reactivity is quantified in Abraxis supporting materials for a few select chemically 
similar compounds for each analyte; the one most likely to prove relevant to this research is the 
cross-reactivity between estradiol and estrone. Estrone is rated at 75% expression as estradiol 
using this kit, which means that degradation of estradiol to estrone will not be totally ignored, 
but will only show up as a quarter of the actual transformation. This indicates that the estrone 
assay, rather than simply adding another valuable measure to this experimental procedure will 
resolve a major blind spot, which is that transformation of estradiol is significantly 
underexpressed. As conversion of estradiol to estrone is associated with physical interaction and 
further mineralization is a microbially-catalyzed process, this means that microbial treatment 
will be over-emphasized relative to physical in estradiol results. 
Association of analytes with organic matter 
 The first data produced relating to this line of inquiry is the trial analysis for estradiol 
performed during the training session 3.28.11. A diluted aliquot of C4 US-1 was split in two, and 
one fraction was filtered (2.7, 1.5 and 0.45 micron filters stacked top to bottom, respectively) 
while the other was not. Comparison of the two found that the unfiltered fraction result was 
136% of the filtered result, indicating that about 26% of the estradiol in the original sample had 
been lost (Table H7).  
Table H7 - Estradiol in filtered and unfiltered aliquots of C4 US-1. 
 
Abraxis 
Values 
C4 US-1 filtered 11 
C4 US-1 
unfiltered 14 
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 This basic experiment was expanded on using both filtered aliquots and aliquots that 
were passed through a SAX cartridge, in order to determine the loss associated with each. SAX 
treatment was in addition to filtration for that aliquot. Two samples were processed in this way: 
a source water sample taken from Reservoir 1 immediately following the collection of G1.2 was 
labeled “settled”, then the reservoir was shaken to mix in any settled content, and a second 
sample was taken, labeled “shaken”. The results from this experiment are presented in Table 
H8, Figures H8-H10. 
 
Table H8 - Analyte concentrations in filtered and SAX treated aliquots of G1.2. 
Sample 
Estradiol 
(ng/L) 
Caffeine 
(ug/l) 
Triclosan 
(ug/l) 
G1.2 47 42.37892 10.49712 
G1.2 Filt Settled 99 38.74394 2.484624 
G1.2 SAX Settled 134 26.87465 2.484624 
G1.2 Filt Shaken 103 26.69181 2.756333 
G1.2 SAX Shaken 133 33.0623 3.438778 
 
    
 
 
Figure H8 - Estradiol recovery following filtration and SAX treatment. 
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Figure H9 - Caffeine recovery following filtration and SAX treatment. 
 
 
Figure H10 - Triclosan recovery following filtration and SAX treatment 
  
The initial experiment conducted to investigate this tendency, the comparison of 
filtered and unfiltered aliquots of C4 conducted during the training session, seemed to have 
given a clear and relevant indication of the tendency for estradiol to adsorb onto organic 
molecules. The follow-up experiment, which included shaken and settled samples from the same 
volume of wastewater, refined the samples by filtration and being drawn through SAX cartridges 
in addition to the untreated portion, and tested for all three target analytes produced results that 
defy logical explanation (Table H8). This experimental concept would produce results relevant 
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would illustrate the principle hypothesized to be responsible for the anomalous trends observed 
in column study samples, and would give an idea of the distribution of analytes between 
suspended particulate and dissolved organic matter. The inclusion of caffeine as a target 
chemical would provide an indication of the importance of solubility. However, something about 
the execution of the experiment that produced these results was flawed to the extent that the 
conclusions simply need to be discarded and the experiment repeated.  
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